<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Hum Mol Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Hum. Mol. Genet</journal-id>
<journal-id journal-id-type="publisher-id">hmg</journal-id>
<journal-id journal-id-type="hwp">hmg</journal-id>
<journal-title-group>
<journal-title>Human Molecular Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">0964-6906</issn>
<issn pub-type="epub">1460-2083</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27131348</article-id>
<article-id pub-id-type="pmc">5181638</article-id>
<article-id pub-id-type="doi">10.1093/hmg/ddw131</article-id>
<article-id pub-id-type="publisher-id">ddw131</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Deletion of CTNNB1 in inhibitory circuitry contributes to autism-associated behavioral defects</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Dong</surname>
<given-names>Fengping</given-names>
</name>
<xref ref-type="aff" rid="ddw131-aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="ddw131-FN2">
<sup>†</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jiang</surname>
<given-names>Joanna</given-names>
</name>
<xref ref-type="aff" rid="ddw131-aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="ddw131-FN2">
<sup>†</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McSweeney</surname>
<given-names>Colleen</given-names>
</name>
<xref ref-type="aff" rid="ddw131-aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zou</surname>
<given-names>Donghua</given-names>
</name>
<xref ref-type="aff" rid="ddw131-aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="ddw131-aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Long</given-names>
</name>
<xref ref-type="aff" rid="ddw131-aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="ddw131-aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mao</surname>
<given-names>Yingwei</given-names>
</name>
<xref ref-type="aff" rid="ddw131-aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="ddw131-cor1">*</xref>
</contrib>
<aff id="ddw131-aff1"><label>1</label>Department of Biology, Pennsylvania State University, University Park, PA 16802, USA</aff>
<aff id="ddw131-aff2"><label>2</label>Department of Neurology, First Affiliated Hospital, Guangxi Medical University, Nanning, Guangxi Province, 530021, China</aff>
<aff id="ddw131-aff3"><label>3</label>Department of Chemistry and Biology, College of Science, National University of Defense Technology, Changsha, Hunan Province 410073, China</aff>
</contrib-group>
<author-notes>
<fn id="ddw131-FN2">
<label>†</label>
<p>These authors contributed equally to this work.</p>
</fn>
<corresp id="ddw131-cor1">*To whom correspondence should be addressed at Department of Biology, Pennsylvania State University, University Park, PA 16802, USA. Tel: +814-321-4739; Fax: +814-863-1357. Email: <email>yzm1@psu.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>01</day>
<month>7</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>30</day>
<month>4</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>30</day>
<month>4</month>
<year>2016</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
<volume>25</volume>
<issue>13</issue>
<fpage>2738</fpage>
<lpage>2751</lpage>
<history>
<date date-type="received">
<day>16</day>
<month>1</month>
<year>2016</year>
</date>
<date date-type="rev-recd">
<day>22</day>
<month>3</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>25</day>
<month>4</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author 2016. Published by Oxford University Press.</copyright-statement>
<copyright-year>2016</copyright-year>
<license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
<license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com</license-p>
</license>
</permissions>
<abstract>
<p>Mutations in β-catenin (CTNNB1) have been implicated in cancer and mental disorders. Recently, loss-of-function mutations of CTNNB1 were linked to intellectual disability (ID), and rare mutations were identified in patients with autism spectrum disorder (ASD). As a key regulator of the canonical Wnt pathway, CTNNB1 plays an essential role in neurodevelopment. However, the function of CTNNB1 in specific neuronal subtypes is unclear. To understand how CTNNB1 deficiency contributes to ASD, we generated CTNNB1 conditional knockout (cKO) mice in parvalbumin interneurons. The cKO mice had increased anxiety, but had no overall change in motor function. Interestingly, CTNNB1 cKO in PV-interneurons significantly impaired object recognition and social interactions and elevated repetitive behaviors, which mimic the core symptoms of patients with ASD. Surprisingly, deleting CTNNB1 in parvalbumin-interneurons enhanced spatial memory. To determine the effect of CTNNB1 KO in overall neuronal activity, we found that c-Fos was significantly reduced in the cortex, but not in the dentate gyrus and the amygdala. Our findings revealed a cell type-specific role of CTNNB1 gene in regulation of cognitive and autistic-like behaviors. Thus, this study has important implications for development of therapies for ASDs carrying the CTNNB1 mutation or other ASDs that are associated with mutations in the Wnt pathway. In addition, our study contributes to a broader understanding of the regulation of the inhibitory circuitry.</p>
</abstract>
<counts>
<page-count count="14"></page-count>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Autism spectrum disorder (ASD) is a class of neurodevelopmental disorders characterized by persistent deficits in social communication and social interaction (<xref ref-type="bibr" rid="ddw131-B1">1</xref>). Patients with ASD often have an increased risk of anxiety (<xref ref-type="bibr" rid="ddw131-B2">2</xref>) and memory deficits (<xref ref-type="bibr" rid="ddw131-B3">3</xref>). The prevalence of ASD is on the rise, and no effective treatments exist. Although the etiology is not completely known, many genetic factors are associated with ASDs (<xref ref-type="bibr" rid="ddw131-B4">4</xref>). Both structural chromosomal changes (chromosomal translocation and copy number variations) and single-gene mutations lead to ASD-related clinical manifestations (<xref ref-type="bibr" rid="ddw131-B5">5</xref>). Recent exome sequencing revealed that many <italic>de novo</italic> nonsense mutations significantly increase the risk for ASD. Intriguingly, <italic>de novo</italic> mutations are enriched in genes that participate in the Wnt pathway, suggesting that the Wnt signaling pathway represents a convergence of the genetic risks in ASD (<xref ref-type="bibr" rid="ddw131-B6">6</xref>). CTNNB1 is a fundamental component of the canonical Wnt signaling pathway and controls cell growth and cell adhesion (<xref ref-type="bibr" rid="ddw131-B7">7</xref>,<xref ref-type="bibr" rid="ddw131-B8">8</xref>). Consistently, nonsense and missense mutations in CTNNB1 were identified in patients with ASD (<xref ref-type="bibr" rid="ddw131-B6">6</xref>) and intellectual disability (ID) (<xref ref-type="bibr" rid="ddw131-B9">9</xref>). CTNNB1 directly interacts with multiple top ASD risk genes within the ASD genetic network (<xref ref-type="bibr" rid="ddw131-B6">6</xref>). That analysis implicated CTNNB1 as an important modulator among 22 ASD risk genes.</p>
<p>Dysregulation of CTNNB1 leads to abnormal brain development (<xref ref-type="bibr" rid="ddw131-B10">10–12</xref>) and defective dendritic morphogenesis (<xref ref-type="bibr" rid="ddw131-B13">13</xref>,<xref ref-type="bibr" rid="ddw131-B14">14</xref>). By interacting with N-cadherin, CTNNB1 shapes synaptic structure (<xref ref-type="bibr" rid="ddw131-B15">15</xref>,<xref ref-type="bibr" rid="ddw131-B16">16</xref>) and regulates excitatory postsynaptic strength (<xref ref-type="bibr" rid="ddw131-B17">17</xref>,<xref ref-type="bibr" rid="ddw131-B18">18</xref>). In addition, the axonal localization and translation of CTNNB1 modulate presynaptic vesicle release (<xref ref-type="bibr" rid="ddw131-B19">19–21</xref>). As a consequence, abnormal levels of CTNNB1 in different brain regions or circuits lead to impaired memory (<xref ref-type="bibr" rid="ddw131-B22">22–24</xref>), and a depression-like phenotype (<xref ref-type="bibr" rid="ddw131-B25">25</xref>). Consistent with the hypothesis that the Wnt signaling is a convergent pathway for ASD, several mouse models with deletions in genes involved in the Wnt pathway show deficiencies in social interaction and repeteative behaviors (<xref ref-type="bibr" rid="ddw131-B26">26–28</xref>). However, the circuitry mechanisms for how CTNNB1 dysfunction leads to the pathogenesis of ASD are largely unknown.</p>
<p>An imbalance of excitatory and inhibitory signals has been implicated in the pathophysiology of ASD. As a major type of GABAergic interneurons, parvalbumin-positive (PV+) interneurons generate fast-spiking inhibitory output (<xref ref-type="bibr" rid="ddw131-B29">29</xref>). Cell densities of GABAergic interneurons, including PV-, calbindin-, and calretinin-positive neurons, are changed in postmortem brains of autism patients (<xref ref-type="bibr" rid="ddw131-B30">30</xref>,<xref ref-type="bibr" rid="ddw131-B31">31</xref>). GAD67 and GAD65, the enzymes required for GABA synthesis, are altered in autism (<xref ref-type="bibr" rid="ddw131-B32">32</xref>,<xref ref-type="bibr" rid="ddw131-B33">33</xref>), and PV neuron abnormality was found in different mouse models of autism (<xref ref-type="bibr" rid="ddw131-B34">34</xref>,<xref ref-type="bibr" rid="ddw131-B35">35</xref>). Particularly, PV knockout mice have behavioral phenotypes similar to all three core symptoms in human ASD patients (<xref ref-type="bibr" rid="ddw131-B36">36</xref>), suggesting PV interneurons represent a major neuron type that mediates ASD pathophysiology. Interneuron deficits have been reported in several psychiatric disorders, including schizophrenia and ASDs (<xref ref-type="bibr" rid="ddw131-B37">37</xref>).</p>
<p>The Wnt signaling pathway is required for proper interneuron development. However, the behavioral function of CTNNB1 in PV interneurons has not been identified. Here we established a CTNNB1 conditional knockout (cKO) mouse specifically in PV interneurons and showed that CTNNB1 cKO mice have increased anxiety, impaired cognition and social interactions, and elevated repetitive behaviors, which mimic some core symptoms of patients with ASD. Interestingly, CTNNB1 deletion in PV-interneurons enhances spatial memory and alters the neuronal activity in the cortex.</p>
</sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title>CTNNB1 knockout changes the distribution of PV<sup>+ </sup>interneurons</title>
<p>To gain new insight into CTNNB1’s functions in inhibitory neural circuits, we selectively eliminated CTNNB1 by Cre-dependent deletion of <italic>lox</italic>P flanked exons 2 and 6, which leads to an unstable protein (<xref ref-type="bibr" rid="ddw131-B12">12</xref>). CTNNB1<sup>flox/flox</sup> mice were mated with PV-Cre mice to generate mice with CTNNB1 cKO in PV interneurons. CTNNB1<sup>flox/flox</sup> mice were used as controls because they express normal levels of CTNNB1 (<xref ref-type="bibr" rid="ddw131-B12">12</xref>). Mice with genotypes of CTNNB1<sup>flox/flox</sup> and PV-Cre; CTNNB1<sup>flox/flox</sup> were selected for behavior tests. All mice tested were born within 5 days, and behavioral tests started after postnatal day 60 (P60). Immunofluorescent staining confirmed that CTNNB1 was deleted from most PV+ neurons (<xref ref-type="fig" rid="ddw131-F1">Fig. 1</xref>A). A few PV+ neurons still expressed CTNNB1 probably due to incomplete recombination by cre recombinase. As PV is expressed postnatally (<xref ref-type="bibr" rid="ddw131-B38">38</xref>), we further tested how deletion of CTNNB1 affects the distribution of PV interneurons. Intriguingly, the density of PV+ neurons in the prefrontal cortex was significantly higher in CTNNB1 cKO mice (<xref ref-type="fig" rid="ddw131-F1">Fig. 1</xref>B). However, the percentages of PV+ neurons in different hippocampal regions, the amygdala, and the hypothalamus were not changed (<xref ref-type="fig" rid="ddw131-F1">Fig. 1</xref>C and D), suggesting the alteration is region-specific. To gain more insights on the developmental distribution of PV+ neurons, we found that at an early developmental time, postnatal day (P22), the localization of PV+ interneurons was not changed by CTNNB1 cKO in the cortex (<ext-link ext-link-type="uri" xlink:href="http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddw131/-/DC1">Supplementary Material, Fig. S1A and B</ext-link>) or the hippocampus (<ext-link ext-link-type="uri" xlink:href="http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddw131/-/DC1">Supplementary Material, Fig. S1C</ext-link>), suggesting that mislocalization of PV cells occurs between P22 and P60.
<fig id="ddw131-F1" orientation="portrait" position="float"><label>Figure 1.</label><caption><p>Abnormal arrangement of PV-positive cells in PV-Cre; CTNNB1<sup>flox/flox</sup> mice. <bold>(A)</bold> Immunofluorescent staining of CTNNB1 in PV+ cells. White arrows indicate PV-positive cells (green). CTNNB1 expression was present in control mice, but was absent in PV-Cre; CTNNB1<sup>flox/flox</sup> mice. Scale bar = 10 µm. <bold>(B)</bold> PV-Cre; CTNNB1<sup>flox/flox</sup> mice (N = 4) showed significant more PV<sup>+ </sup>cells (green) in the prefrontal cortex than CTNNB1<sup>flox/flox</sup> mice (N = 6). Scale bar = 100 µm. <bold>(C)</bold> Similar percentages of PV+ neurons were detected in the hippocampal regions. <bold>(D)</bold> Similar number of PV+ neurons were localized at the amygdala and the hypothalamus . *<italic>P</italic> &lt; 0.05, **<italic>P</italic> &lt; 0.01.</p></caption><graphic xlink:href="ddw131f1p"></graphic></fig>
</p>
</sec>
<sec>
<title>CTNNB1 cKO in PV interneurons increases anxiety but not depression-related behavior</title>
<p>To determine if CTNNB1 cKO in PV interneurons affects any motor function, we examined them in the open field test (OFT). PV-Cre; CTNNB1<sup>flox/flox</sup> mice and controls had no differences in total distance travelled (<xref ref-type="fig" rid="ddw131-F2">Fig. 2</xref>A), speed (<ext-link ext-link-type="uri" xlink:href="http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddw131/-/DC1">Supplementary Material, Fig. S2A and B</ext-link>), total time mobile (<ext-link ext-link-type="uri" xlink:href="http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddw131/-/DC1">Supplementary Material, Fig. S2C</ext-link>), and total vertical rearing activity (<ext-link ext-link-type="uri" xlink:href="http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddw131/-/DC1">Supplementary Material</ext-link>, Fig. S2D). In addition, the rotarod test showed no significant difference between the groups (<ext-link ext-link-type="uri" xlink:href="http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddw131/-/DC1">Supplementary Material, Fig. S3</ext-link>). These data demonstrated that PV-Cre; CTNNB1<sup>flox/flox</sup> mice had no deficits in motor coordination and locomotor function. However, significant differences were detected on center duration time, center distance traveled, frequency and latency of center entry. In the OFT, PV-Cre; CTNNB1<sup>flox/flox</sup> mice had significantly less center distance traveled (<italic>P </italic>= 0.01) (<xref ref-type="fig" rid="ddw131-F2">Fig. 2</xref>B), with similar velocities (<italic>P </italic>= 0.76) (<xref ref-type="fig" rid="ddw131-F2">Fig. 2</xref>C). In the 5-min test, PV-Cre; CTNNB1<sup>flox/flox</sup> mice spent less time in the center region (<italic>P </italic>= 0.03) (<xref ref-type="fig" rid="ddw131-F2">Fig. 2</xref>D). PV-Cre; CTNNB1<sup>flox/flox</sup> mice showed less center entry (<italic>P </italic>= 0.02) (<xref ref-type="fig" rid="ddw131-F2">Fig. 2</xref>E) and a longer latency to enter the center region (<italic>P </italic>= 0.005) (<xref ref-type="fig" rid="ddw131-F2">Fig. 2</xref>F). The evidence from of OFT showed that mice with CTNNB1 cKO in PV neurons avoid traveling in the center region (<xref ref-type="fig" rid="ddw131-F2">Fig. 2</xref>G), suggesting an increase of anxiety in CTNNB1 cKO mice.
<fig id="ddw131-F2" orientation="portrait" position="float"><label>Figure 2.</label><caption><p>PV-Cre; CTNNB1<sup>flox/flox</sup> mice display anxiety-like behavior. <bold>(A)</bold> In the OFT, two groups of mice traveled similar total distances. <bold>(B)</bold> PV-Cre; CTNNB1<sup>flox/flox</sup> mice travelled less in the center. <bold>(C)</bold> Velocity in the center. <bold>(D)</bold> PV-Cre; CTNNB1<sup>flox/flox</sup> mice spent less time in the center than controls. <bold>(E)</bold> Center entry. <bold>(F)</bold> Latency for the first entry into the center. <bold>(G)</bold> Schematics showed the zone setting and representative traces of mouse movement. Data shown are mean ± SEM from CTNNB1<sup>flox/flox</sup> (N = 18) and PV-Cre; CTNNB1<sup>flox/flox</sup> groups (N = 10). *<italic>P</italic> &lt; 0.05, **<italic>P</italic> &lt; 0.01.</p></caption><graphic xlink:href="ddw131f2p"></graphic></fig>
</p>
<p>To confirm the elevated anxiety-like behaviors in CTNNB1 cKO mice, we used the elevated plus maze (EPM), a well-established test for assessing anxiety responses in rodents (<xref ref-type="bibr" rid="ddw131-B39">39</xref>). PV-Cre; CTNNB1<sup>flox/flox</sup> mice showed a significant difference on the latency of arms entry compared to littermate controls. It took much longer (<italic>P </italic>= 0.048) for CTNNB1 cKO mice to enter open arms (<xref ref-type="fig" rid="ddw131-F3">Fig. 3</xref>A). They entered the closed arms much earlier (<italic>P </italic>= 0.002) than the CTNNB1<sup>flox/flox</sup> mice (<xref ref-type="fig" rid="ddw131-F3">Fig. 3</xref>A), suggesting that cKO mice are more anxious. CTNNB1<sup>flox/flox</sup> mice showed a similar frequency entering either open or closed arms (<xref ref-type="fig" rid="ddw131-F3">Fig. 3</xref>B). However, PV-Cre; CTNNB1<sup>flox/flox</sup> mice preferred the closed arms more often than the open arms (<italic>P </italic>= 0.0007), and they entered the closed arms more frequently than the control mice (<italic>P </italic>= 0.014) (<xref ref-type="fig" rid="ddw131-F3">Fig. 3</xref>B). Although two groups traveled similar total distance in closed and open arms (<xref ref-type="fig" rid="ddw131-F3">Fig. 3</xref>C), the distance traveled in the open arm was much less than in the PV-Cre; CTNNB1<sup>flox/flox</sup> mice (<italic>P </italic>= 0.06) (<xref ref-type="fig" rid="ddw131-F3">Fig. 3</xref>C and E). CTNNB1 cKO mice spent similar time in open and closed arms as littermate controls (<ext-link ext-link-type="uri" xlink:href="http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddw131/-/DC1">Supplementary Material, Fig. S4A</ext-link>). Although it did not reach significance, they tended to spend more time in the center region (<italic>P </italic>= 0.08) and less time in the distal half of the open arms (<italic>P</italic> = 0.07) (<ext-link ext-link-type="uri" xlink:href="http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddw131/-/DC1">Supplementary Material, Fig. S4B</ext-link>). Consistent with increased anxiety-like behaviors, CTNNB1 cKO mice were reluctant to enter the distal half of the open arms (<italic>P </italic>= 0.02) (<ext-link ext-link-type="uri" xlink:href="http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddw131/-/DC1">Supplementary Material, Fig. S4C</ext-link>). Head-dipping is a compulsive-like behavior that is a high risk for anxiety (<xref ref-type="bibr" rid="ddw131-B39">39</xref>,<xref ref-type="bibr" rid="ddw131-B40">40</xref>). PV-Cre; CTNNB1<sup>flox/flox</sup> mice significantly increased their head-dipping behavior (<italic>P </italic>= 0.047), especially at the center region of the plus maze apparatus (<italic>P </italic>&lt; 0.001) (<xref ref-type="fig" rid="ddw131-F3">Fig. 3</xref>D). Rearing behavior did not significantly increase in our test (<ext-link ext-link-type="uri" xlink:href="http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddw131/-/DC1">Supplementary Material, Fig. S4D</ext-link>). It may be that PV-Cre; CTNNB1<sup>flox/flox</sup> mice traveled less in the open arms. Our results from the OFT and EPM indicated that CTNNB1 KO in PV<sup>+ </sup>neurons leads to an increase of anxiety behaviors.
<fig id="ddw131-F3" orientation="portrait" position="float"><label>Figure 3.</label><caption><p>PV-Cre; CTNNB1<sup>flox/flox</sup> mice increase anxiety-like behavior. <bold>(A)</bold> In the EPM test, PV-Cre; CTNNB1<sup>flox/flox</sup> mice showed longer latency to enter open arms and shorter latency to enter closed arms. <bold>(B)</bold> PV-Cre; CTNNB1<sup>flox/flox</sup> mice were prone to enter closed arms more frequently. <bold>(C)</bold> PV-Cre; CTNNB1<sup>flox/flox</sup> mice showed a trend to travel less in open arms. <bold>(D)</bold> PV-Cre; CTNNB1<sup>flox/flox</sup> mice showed significantly more head-dipping behavior. <bold>(E)</bold> Schematics show the zones of the EPM and representative traces of mouse movement. Data shown are mean ± SEM from the CTNNB1<sup>flox/flox</sup> (N = 18) and PV-Cre; CTNNB1<sup>flox/flox</sup> groups (N = 10). *<italic>P</italic> &lt; 0.05, **<italic>P</italic> &lt; 0.01, ***<italic>P</italic> &lt; 0.001, NS, non-significant.</p></caption><graphic xlink:href="ddw131f3p"></graphic></fig>
</p>
<p>The tail suspension test assesses the efficacy of anti-depressant drugs and determines depression-related behavior in genetic mouse models (<xref ref-type="bibr" rid="ddw131-B41">41</xref>). In this test, the depression-related behavior of our mice was not affected (<ext-link ext-link-type="uri" xlink:href="http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddw131/-/DC1">Supplementary Material, Fig. S5</ext-link>). The immobile time (lack of struggle-related behavior) was not significantly altered in CTNNB1 cKO mice (<italic>P </italic>= 0.237).</p>
</sec>
<sec>
<title>CTNNB1 cKO in PV neurons alters recognition performance</title>
<p>Because mutations in CTNNB1 result in IDs (<xref ref-type="bibr" rid="ddw131-B9">9</xref>) and PV interneurons modulate cognitive functions (<xref ref-type="bibr" rid="ddw131-B42">42</xref>), we tested how CTNNB1 defects in PV interneurons alter cognitive function and memory. Using the novel object recognition (NOR) test, mice were exposed to different objects after acclimation to a pair of identical objects. No significant difference was found between CTNNB1 cKO mice and control littermates when interacting with two identical objects (<ext-link ext-link-type="uri" xlink:href="http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddw131/-/DC1">Supplementary Material, Fig. S6A and B</ext-link>), suggesting that the presence of objects did not alter their exploratory behaviors. One hour after acclimation, one familiar object was replaced with a novel object. Both groups of mice showed increased interest in the novel object. Both interactive duration and frequency of novel object were higher than with the familiar object (<xref ref-type="fig" rid="ddw131-F4">Fig. 4</xref>A and B). These data suggest that CTNNB1 cKO mice maintain normal short-term memory (1 h). After 24 h, the animals were retested when novel object 1 was paired with novel object 2. The control mice spent significantly more time with the novel object 2 (<italic>P </italic>= 0.028) (<xref ref-type="fig" rid="ddw131-F4">Fig. 4</xref>C), suggesting that they retained long-term memory. However, PV-Cre; CTNNB1<sup>flox/flox</sup> mice had similar interactive durations and frequencies between novel object 2 and the familiar object (<italic>P </italic>= 0.9) (<xref ref-type="fig" rid="ddw131-F4">Fig. 4</xref>C, <ext-link ext-link-type="uri" xlink:href="http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddw131/-/DC1">Supplementary Material, Fig. S6C</ext-link>). The NOR test indicated that CTNNB1 cKO from PV<sup>+ </sup>neurons affected the long-term recognition but not the short-term memory.
<fig id="ddw131-F4" orientation="portrait" position="float"><label>Figure 4.</label><caption><p>PV-Cre; CTNNB1<sup>flox/flox</sup> mice show memory deficits in the NOR test. <bold>(A)</bold> Both groups of mice interacted with a novel object longer than a familiar object after 1 h. <bold>(B)</bold> Both groups of mice were prone to interact with novel object more frequently than a familiar object after 1 h. <bold>(C)</bold> After replacing to another novel object in 24 h, CTNNB1<sup>flox/flox</sup> mice spent more time on novel object 2, but PV-Cre; CTNNB1<sup>flox/flox</sup> showed no preference. <bold>(D)</bold> In the contextual fear conditioning freezing test, PV-Cre; CTNNB1<sup>flox/flox</sup> mice did not decrease the percentage of freezing at the third day of extinction tests. Data shown are mean ± SEM from the CTNNB1<sup>flox/flox</sup> (N = 18) and PV-Cre; CTNNB1<sup>flox/flox</sup> groups (N = 10). *<italic>P</italic> &lt; 0.05, **<italic>P</italic> &lt; 0.01. F, familiar object. N1, novel object 1, N2, novel object 2.</p></caption><graphic xlink:href="ddw131f4p"></graphic></fig>
</p>
<p>PV interneurons synchronize spiking activity in neuronal networks and modulate fear memory (<xref ref-type="bibr" rid="ddw131-B43">43</xref>,<xref ref-type="bibr" rid="ddw131-B44">44</xref>). Because long-term recognition memory was changed in CTNNB1 cKO mice, we examined fear memory with a fear conditioning and extinction paradigm. No significant difference was detected in the contextual fear conditioning test during the first 2 days, suggesting that the CTNNB1 cKO mice had an intact fear memory. Interestingly, CTNNB1 cKO mice retained a high freezing percentage, and control littermates showed significant reduced extinction formation on day 3 (<xref ref-type="fig" rid="ddw131-F4">Fig. 4</xref>D). These data indicate that CTNNB1 cKO in PV+ neurons did not change the contextual fear condition. However, memory extinction was impaired as new memories cannot be formed in CTNNB1 cKO mice.</p>
</sec>
<sec>
<title>PV-Cre; CTNNB1<sup>flox/flox</sup> mice exhibits enhanced spatial memory</title>
<p>Several autistic mouse models showed abnormal spatial memory (<xref ref-type="bibr" rid="ddw131-B45">45–49</xref>). We used the Morris water maze (MWM) assay to measure spatial memory. Within 4 training days, PV-Cre; CTNNB1<sup>flox/flox</sup> mice took less time (<xref ref-type="fig" rid="ddw131-F5">Fig. 5</xref>A) and swam shorter distances (<xref ref-type="fig" rid="ddw131-F5">Fig. 5</xref>B) to reach the platform. They also showed a higher percentage of successful rate of finding the hidden-platform within 60 s (<xref ref-type="fig" rid="ddw131-F5">Fig. 5</xref>C). On the testing day, after the platform was removed, we measured the time spent in the four quadrants, based on the position of the platform. PV-Cre; CTNNB1<sup>flox/flox</sup> mice showed decreased travel distance (<italic>P </italic>= 0.003) (<xref ref-type="fig" rid="ddw131-F5">Fig. 5</xref>D), longer duration (<italic>P </italic>= 0.03) (<xref ref-type="fig" rid="ddw131-F5">Fig. 5</xref>F) and greater travel frequency (<italic>P </italic>= 0.02) (<xref ref-type="fig" rid="ddw131-F5">Fig. 5</xref>G) into the platform quadrant than control littermates. Furthermore, to better quantify spatial memory, we used a three-zone assessment with concentric circles of different diameters surrounding the platform (<xref ref-type="fig" rid="ddw131-F5">Fig. 5</xref>E). Interestingly, PV-Cre; CTNNB1<sup>flox/flox</sup> mice showed better navigation to the target. They had significantly shorter latencies to reach the smallest target zone (<italic>P </italic>= 0.02), spent significantly longer time (<italic>P </italic>= 0.02), and entered more (<italic>P </italic>= 0.01) in the target zones (<xref ref-type="fig" rid="ddw131-F5">Fig. 5</xref>H–J). These indicate that PV-Cre; CTNNB1<sup>flox/flox</sup> mice can memorize the position of the platform in relation to spatial cues with higher accuracy.
<fig id="ddw131-F5" orientation="portrait" position="float"><label>Figure 5.</label><caption><p>Spatial memory was enhanced in PV-Cre; CTNNB1<sup>flox/flox</sup> mice. <bold>(A)</bold> The accuracy of both groups to reach the platform increased with training. However, PV-Cre; CTNNB1<sup>flox/flox</sup> mice took less time to reach the platform. <bold>(B)</bold> PV-Cre; CTNNB1<sup>flox/flox</sup> mice took short distances to reach the platform. <bold>(C)</bold> The percentage of reaching the platform within 60 s was higher in CTNNB1 cKO group. <bold>(D)</bold> On the testing day, total distance traveled significantly decreased in PV-Cre; CTNNB1<sup>flox/flox</sup> mice. <bold>(E)</bold> Schematics show the representative traces of mouse movement in the MWM. <bold>(F)</bold> CTNNB1 cKO mice spent longer duration in the platform quadrant. <bold>(G)</bold> CTNNB1 cKO mice entered more frequently into the platform quadrant. <bold>(H)</bold> To better evaluate the performance of mice, we generated three concentric circles around the platform with different diameters as shown in (E). PV-Cre; CTNNB1<sup>flox/flox</sup> mice took shorter latency to the smallest zone. <bold>(I)</bold> PV-Cre; CTNNB1<sup>flox/flox</sup> mice spent longer duration in the smallest zone. <bold>(J)</bold> PV-Cre; CTNNB1<sup>flox/flox</sup> mice entered more into the smallest zone. *<italic>P</italic> &lt; 0.05, **<italic>P</italic> &lt; 0.01.</p></caption><graphic xlink:href="ddw131f5p"></graphic></fig>
</p>
</sec>
<sec>
<title>CTNNB1 cKO in PV neurons alters social behaviors and increased repetitive behaviors</title>
<p>ASD is characterized by social-interaction difficulties and repetitive behaviors. The social interaction test (SIT) uses a three-chamber paradigm to examine social memory and social novelty in mice. Both groups of mice showed no preference for empty chambers during the habituation (<ext-link ext-link-type="uri" xlink:href="http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddw131/-/DC1">Supplementary Material, Fig. S7A</ext-link>). When a mouse is presented with an empty chamber, both control (<italic>P </italic>&lt; 0.001) and PV-Cre; CTNNB1<sup>flox/flox</sup> mice (<italic>P </italic>&lt; 0.01) preferred to interact more with the mouse rather than the empty chamber (<xref ref-type="fig" rid="ddw131-F6">Fig. 6</xref>A and B), suggesting that both groups of mice maintain normal social motivation. In the second session, an unfamiliar mouse, was introduced in the empty chamber. The CTNNB1<sup>flox/flox</sup> mice preferred to interact with the unfamiliar mouse with significant higher interacting time (<italic>P </italic>&lt; 0.001) and frequency (<italic>P </italic>= 0.015) (<xref ref-type="fig" rid="ddw131-F6">Fig. 6</xref>C–E). In contrast, PV-Cre; CTNNB1<sup>flox/flox</sup> mice failed to show social novelty behavior in this session.
<fig id="ddw131-F6" orientation="portrait" position="float"><label>Figure 6.</label><caption><p>Social memory deficits in PV-Cre; CTNNB1<sup>flox/flox</sup> mice. <bold>(A)</bold> In the first section of SIT, both groups interacted with a mouse more frequently than the empty chamber. <bold>(B)</bold> Both groups spent longer time with a mouse frequently than the empty chamber. <bold>(C)</bold> In the second section of SIT, an unfamiliar mouse was introduced in the empty chamber. CTNNB1<sup>flox/flox</sup> mice was prone to interact with unfamiliar mice more frequently, but PV-Cre; CTNNB1<sup>flox/flox</sup> mice failed to differentiate the familiar mouse and the unfamiliar mouse. <bold>(D)</bold> PV-Cre; CTNNB1<sup>flox/flox</sup> mice spent similar time with familiar mice and unfamiliar mice. <bold>(E)</bold> Schematics showed the representative traces of mouse movement. Data shown are mean ± SEM from the CTNNB1<sup>flox/flox</sup> (N = 18) and PV-Cre; CTNNB1<sup>flox/flox</sup> groups (N = 10). *<italic>P</italic> &lt; 0.05, **<italic>P</italic> &lt; 0.01, ***<italic>P</italic> &lt; 0.001. E, empty chamber;F, familiar mouse; U, unfamiliar mouse.</p></caption><graphic xlink:href="ddw131f6p"></graphic></fig>
</p>
<p>Another core symptom of ASD is repetitive behavior. To determine if CTNNB1 cKO in PV+ neurons leads to changes of repetitive behavior, we measured the total grooming time in a testing session of 25 min. CTNNB1 cKO mice had significantly more grooming time than their control littermates (<italic>P </italic>= 0.033) (<xref ref-type="fig" rid="ddw131-F7">Fig. 7</xref>A). The marble burying test (MBT) has been used to study stereotypic behaviors related to obsessive-compulsive disorder (<xref ref-type="bibr" rid="ddw131-B50">50</xref>), which also reflects a repetitive and perseverative behavior in ASD patients. PV-Cre; CTNNB1<sup>flox/flox</sup> mice took more time to start to bury the marbles (<italic>P </italic>= 0.046) (<xref ref-type="fig" rid="ddw131-F7">Fig. 7</xref>B). This result may also reflect increased anxiety in CTNNB1 cKO mice. Yet the final number of buried marbles was not statistically different in the two groups (<italic>P </italic>= 0.758) (<ext-link ext-link-type="uri" xlink:href="http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddw131/-/DC1">Supplementary Material, Fig. S8</ext-link>). Thus, CTNNB1 cKO mice dug more frequently in a shorter active period. Some autism mouse models also showed problems with nest building (<xref ref-type="bibr" rid="ddw131-B51">51</xref>). Nesting has been reported to be related with defects in the septum or the hippocampus (<xref ref-type="bibr" rid="ddw131-B52">52</xref>,<xref ref-type="bibr" rid="ddw131-B53">53</xref>). PV-Cre; CTNNB1<sup>flox/flox</sup> mice performed worse on nest building test than control mice at different times. The scores were significant lower at 1 (<italic>P </italic>= 0.02) or 24 (<italic>P </italic>= 0.04) h after setting up the nesting (<xref ref-type="fig" rid="ddw131-F7">Fig. 7</xref>C). Moreover, we have tested the effect of gender in several behavioral tests (<ext-link ext-link-type="uri" xlink:href="http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddw131/-/DC1">Supplementary Material, Figs. S2E–H, S4E–G and S7B</ext-link>). There is no significant difference between females and males with the same genotype. Between different genotypes, both males and female went the same direction in several tests. Thus, we believe that it will not affect our interpretation when grouping them together. Our data suggest that CTNNB1 KO in PV+ neurons alter the neuronal network and lead to autistic-like behaviors.
<fig id="ddw131-F7" orientation="portrait" position="float"><label>Figure 7.</label><caption><p>Abnormal repetitive behaviors in PV-Cre; CTNNB1<sup>flox/flox</sup> mice. <bold>(A)</bold> PV-Cre; CTNNB1<sup>flox/flox</sup> mice spent more time on grooming, which is considered a repetitive compulsive behavior. <bold>(B)</bold> In the MBT, PV-Cre; CTNNB1<sup>flox/flox</sup> mice were significantly delayed to start burying. <bold>(C)</bold> They performed worse in nest building than the control littermates measured at multiple times. Especially at 1 and 24 h, their scores were significantly lower than those of the controls. Data shown are mean ± SEM from Ctnnb1<sup>flox/flox</sup> (N = 18) and PV-Cre; Ctnnb1<sup>flox/flox</sup> groups (N = 10). *<italic>P</italic> &lt; 0.05.</p></caption><graphic xlink:href="ddw131f7p"></graphic></fig>
</p>
</sec>
<sec>
<title>CTNNB1 cKO in PV neurons modulates neuronal activity in the cortex</title>
<p>Three forebrain structures, the prefrontal cortex, the amygdala and the hippocampus, form a dynamic neuronal network to regulate anxiety-related behaviors and modulate social interaction (<xref ref-type="bibr" rid="ddw131-B54">54</xref>). To determine the effect of CTNNB1 KO in overall neuronal activity, we sought to determine c-Fos expression in the three brain regions of awake animals. Under a stimulated condition, in which the mice received a brief foot shot 1 h before sacrifice, we found that c-Fos positive cells was significantly reduced in the prefrontal cortex (<xref ref-type="fig" rid="ddw131-F8">Fig. 8</xref>A), but not in the hippocampus subregions and the amygdala of CTNNB1 cKO mice (<xref ref-type="fig" rid="ddw131-F8">Fig. 8</xref>B and C). Particularly, majority of c-Fos+ cells were detected in the layer II (<italic>P </italic>= 0.03) and V (<italic>P </italic>= 0.006) of the prefrontal cortex. In either layer c-Fos+ cells were significantly decreased in cKO mice (<xref ref-type="fig" rid="ddw131-F8">Fig. 8</xref>A), suggesting an elevated level of inhibition. Although a similar damping trend was observed in the amygdala (<italic>P </italic>= 0.07) (<xref ref-type="fig" rid="ddw131-F8">Fig. 8</xref>B), it didn’t reach the statistical significance. This data is consistent with an increased inhibition in the cortex due to a higher density of PV interneurons (<xref ref-type="fig" rid="ddw131-F1">Fig. 1</xref>A), suggesting that PV circuits in the prefrontal cortex may contribute to CTNNB1 cKO mediated behavioral changes.
<fig id="ddw131-F8" orientation="portrait" position="float"><label>Figure 8.</label><caption><p>Abnormal neuronal activity in PV-Cre; CTNNB1<sup>flox/flox</sup> mice. <bold>(A)</bold> The number of c-Fos+ cells was significantly decreased at layer II and V of the cortex in PV-Cre; CTNNB1<sup>flox/flox</sup> mice. <bold>(B)</bold> Distribution of c-Fos+ cells at the amygdala region was not significantly changed in control and PV-Cre; CTNNB1<sup>flox/flox</sup> mice. <bold>(C)</bold> Distribution of c-Fos+ cells did not showed a significant change at the hippocampus regions. *<italic>P</italic> &lt; 0.05. **<italic>P</italic> &lt; 0.01.</p></caption><graphic xlink:href="ddw131f8p"></graphic></fig>
</p>
</sec>
</sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>Our results demonstrate that deleting CTNNB1 in PV interneurons significantly disrupts social and cognitive functions. This study provides the important evidence of CTNNB1’s role in the inhibitory circuit <italic>in vivo.</italic> Our data links a deficit of CTNNB1 in PV interneurons directly to autistic-like behaviors. First, cKO of CTNNB1 in the PV interneurons causes anxiogenic effect in the OFT and EPM, but does not elicit depression-like behaviors, which is consistent with the increased anxiety in patients with ASD (<xref ref-type="bibr" rid="ddw131-B55">55</xref>). Second, CTNNB1 cKO alters multiple cognitive functions. In particular, CTNNB1 loss-of-function impairs long-term memory in the NOR test and fear extinction. However, short-term memory in the NOR and fear memory remain intact. Intriguingly, spatial memory is enhanced by CTNNB1 cKO in PV interneurons. Third, KO of CTNNB1 in the PV interneurons leads to deficit in social interaction and increased repetitive behaviors that mimic core symptoms of ASD patients. Moreover, neuronal activation was significantly reduced in the cortex of cKO mice. Thus, these results support that an optimal level of CTNNB1 in either inhibitory or excitatory neurons is critical to keep normal cognitive and emotional functions.</p>
<p>Different from the phenotypes observed in mice with CTNNB1 KO in excitatory neurons (<xref ref-type="bibr" rid="ddw131-B25">25</xref>), which exhibit depression-like behavior, but not anxiety-related behaviors, we found that PV interneuron-specific cKO leads to increased anxiety without depression phenotype. PV+ interneurons are fast-spiking neurons that inhibit excitatory activity. Our data suggest that CTNNB1 in the inhibitory circuit controls opposite behaviors observed in the excitatory circuit. Consistently, CTNNB1 in the nucleus accumbens confers pro-resilient and anxiolytic effects through a microRNA-dependent mechanism (<xref ref-type="bibr" rid="ddw131-B56">56</xref>), supporting a critical role of CTNNB1 in regulating anxiety. Furthermore, CTNNB1 stability is controlled by GSK3β, which is implicated in mental illness. Lithium, a widely-used mood stabilizer for patients with bipolar disorder, inhibits GSK3β <italic>in vivo</italic> (<xref ref-type="bibr" rid="ddw131-B57">57</xref>). GSK3β is a major mediator of anxiety and the lithium effect (<xref ref-type="bibr" rid="ddw131-B58">58</xref>,<xref ref-type="bibr" rid="ddw131-B59">59</xref>). Overexpression of CTNNB1 in the mouse brain phenocopies the anti-depressant effects of lithium in the amphetamine model (<xref ref-type="bibr" rid="ddw131-B60">60</xref>), suggesting that lithium modulates behaviors through the GSK3β-CTNNB1 pathway. Our data, together with these studies, demonstrate that an optimal level of CTNNB1 in both excitatory neurons and inhibitory neurons is critical for normal emotional behaviors.</p>
<p>Here we showed that a novel role of CTNNB1 in PV interneurons to modulate social interaction and spatial learning. PV interneurons control the synchronization of the brain activities and are essential in learning behaviors. Imbalance of excitation and inhibition has been implicated in multiple psychiatric disorders, such as schizophrenia (<xref ref-type="bibr" rid="ddw131-B61">61</xref>,<xref ref-type="bibr" rid="ddw131-B62">62</xref>) and ASDs. Consistent with its critical role in memory, we found that PV interneuron-specific KO causes deficits in objective recognition and social memory. The short-term memory and contextual fear learning in PV interneuron-specific cKO mice were not affected, suggesting that memory acquisition was intact. Interestingly, the results that CTNNB1 PV-KO mice failed to recognize the second novel object in the NOR test and the second stranger mouse in the SIT, as well as to extinguish fear memory, indicate a deficit in the ability to acquire new information and to replace previous memories. This cognitive inflexibility is seen in autistic patients (<xref ref-type="bibr" rid="ddw131-B63">63</xref>,<xref ref-type="bibr" rid="ddw131-B64">64</xref>) and is consistent with phenotypes of mice expressing stabilized CTNNB1 during reversal learning tasks (<xref ref-type="bibr" rid="ddw131-B24">24</xref>). Intriguingly, our mouse model showed enhanced spatial memory, which is consistent with other autistic mouse models with defect in Shank1 (<xref ref-type="bibr" rid="ddw131-B49">49</xref>) and neuroligin-3 (<xref ref-type="bibr" rid="ddw131-B45">45</xref>), but not with others (<xref ref-type="bibr" rid="ddw131-B46">46</xref>,<xref ref-type="bibr" rid="ddw131-B65">65</xref>). Increased spatial memory could be a CTNNB1 specific effect. However, patients with ASDs can display normal or, rarely, even enhanced cognitive abilities (<xref ref-type="bibr" rid="ddw131-B66">66</xref>,<xref ref-type="bibr" rid="ddw131-B67">67</xref>). Thus, we cannot exclude the possibility that this alteration by CTNNB1 KO could contribute to ASD pathophysiology as the genetics and symptoms of ASDs are quite heterogeneous.</p>
<p>Our study indicates that CTNNB1 cKO in PV interneurons is sufficient to modify the circuit development, resulting in more PV interneurons localizing in the cortex region even though PV is mainly expressed postnatally. CTNNB1 is the key mediator in the canonical Wnt signaling pathway, which involves a variety of cellular processes, including development, cell proliferation, cell survival, and motility. During early neurodevelopment, CTNNB1 fine-tunes the balance of proliferation and differentiation of neural stem cells. Both loss- and gain-of-function of CTNNB1 resulted in neurodevelopmental deficits (<xref ref-type="bibr" rid="ddw131-B8">8</xref>,<xref ref-type="bibr" rid="ddw131-B10">10</xref>). Additionally, the Wnt signaling pathway controls interneuron differentiation (<xref ref-type="bibr" rid="ddw131-B68">68</xref>), thereby balancing the excitatory and inhibitory signals at a cellular level. Since PV is expressed postnatally (<xref ref-type="bibr" rid="ddw131-B69">69</xref>), CTNNB1 does not likely work by regulating interneuron progenitor differentiation. Our data indicated that the localization of PV+ interneurons was not changed by CTNNB1 KO at P22 in the cortex. As at this age, proliferation and fate specification of interneuron progenitors have completed, our data suggest that mislocalization of PV cells occurs between P22 and P60, and is likely caused by a migration defect. Moreover, the number of PV + cells in other brain regions was not changed. PV has not been shown as a direct downstream target of the Wnt pathway. This further supported that the change of PV distribution is not caused by abnormal proliferation, or altered fate determination, or modulation of PV expression. CTNNB1 might modulate migration via α-catenin-extracellular matrix interaction. However, the exact molecular mechanism on how CTNNB1 in PV neurons controls their distribution remains to be determined.</p>
<p>Our findings provide new insights into human CTNNB1 gene mutations in the inhibitory circuits as a risk factor for ASD/ID. Mutations in the Wnt pathway are enriched in the genetic risks in ASD (<xref ref-type="bibr" rid="ddw131-B6">6</xref>). Consistently, mutations of CTNNB1 were identified in patients with ASD (<xref ref-type="bibr" rid="ddw131-B6">6</xref>) and ID (<xref ref-type="bibr" rid="ddw131-B9">9</xref>). Previous studies did not identify autistic-like behaviors, including anxiety, social interaction deficit and repetitive behaviors, on mouse models with CTNNB1 KO in excitatory neurons (<xref ref-type="bibr" rid="ddw131-B22">22</xref>,<xref ref-type="bibr" rid="ddw131-B24">24</xref>,<xref ref-type="bibr" rid="ddw131-B25">25</xref>,<xref ref-type="bibr" rid="ddw131-B60">60</xref>). Our study reveals that CTNNB1 KO in PV interneurons leads to cognitive and autistic-like phenotypes, suggesting that CTNNB1 defects in PV interneurons are responsible for the core symptoms of autistic-like behaviors. CTNNB1 interacts with α-catenin and N-cadherin to form cell adhesion complex localized at cell membrane and in synaptic junctions (<xref ref-type="bibr" rid="ddw131-B21">21</xref>,<xref ref-type="bibr" rid="ddw131-B70">70</xref>). It controls the synaptic strength and modulates neuronal plasticity in excitatory neurons (<xref ref-type="bibr" rid="ddw131-B15">15</xref>,<xref ref-type="bibr" rid="ddw131-B16">16</xref>,<xref ref-type="bibr" rid="ddw131-B18">18</xref>,<xref ref-type="bibr" rid="ddw131-B20">20</xref>). CTNNB1 may also regulate the electrophysiology of interneurons. Consistent with this notion, c-Fos staining was significantly reduced in the cortex, but not in the dentate gyrus and the amygdala, suggesting that an increased inhibition in the cortex, which may contribute to CTNNB1 KO-mediated behavioral changes. This data is consistent with increased inhibition in the cortex due to a higher density of PV interneurons. Future studies will be required to further delineate the underlying pathophysiological mechanisms. It would be interesting to further narrow down if CTNNB1 deletion from different brain regions or interneuron subtype will mediate particular phenotypes. Such studies will provide a better understanding of circuitry mechanism for ASD and might be potentially useful to design a new strategy to alleviate ASD symptoms.</p>
</sec>
<sec sec-type="materials|methods">
<title>Materials and Methods</title>
<sec>
<title>Animals</title>
<p>The CTNNB1<sup>flox/flox</sup> mice (B6.129-CTNNB1<sup><italic>tm2Kem</italic></sup>/<italic>KnwJ</italic>) and the PV-Cre mice (B6; 129P2-Pvalb<sup><italic>tm1(cre)Arbr</italic></sup>/J) from the Jackson Laboratory (Bar Harbor, ME) were used to produce the heterozygous offspring. PV-Cre; CTNNB1 <sup>flox/flox</sup> mouse model were generated by backcrossing of F1 hybrids. All mice (two to four mice per cage) were housed at an ambient room temperature (20–22°C) with a 12-h light/12-h dark cycle (lights on at 6:00 am), and given ad libitum access to food and water. All animal experiments and procedures were reviewed and approved by The Pennsylvania State University IACUC committee.</p>
</sec>
<sec>
<title>Immunohistochemistry</title>
<p>Mice were anesthetized with Avertin (200 mg per kg of body weight) and perfused with artificial cerebrospinal fluid and 4% performic acid (PFA). To investigate the neuronal activity using c-Fos immunohistochemistry, mice were stimulated by three times of 2-s, 0.55-mA foot shock within 250 s and put back to the original cage. One hour after the stimulation, mice were perfused. After post-fixation with 4% PFA for 24 h, brains were sliced by vibratome at the thickness of 50 µm. Each slide was pre-blocked with 5% donkey serum and 0.2% Triton X-100 in phosphate-buffered saline (PBS) for 1 h at room temperature. Primary antibodies were mixed in fresh blocking solution and incubate with brain slides for overnight at 4°C. After washing with PBS and 0.1% Triton X-100, brain slides were incubated with secondary antibodies conjugated with fluorescent groups. Brain slides were mounted to glass slides and photographed by confocal microscope. Image J was used for analysis of images. Antibodies used in this study are: rabbit anti-c-Fos antibody (Sigma), rabbit anti-PV antibody (Synaptic Systems), mouse anti-CTNNB1 antibody (BD Transduction Laboratories).</p>
</sec>
<sec>
<title>Behavior Tests</title>
<p>CTNNB1<sup>flox/flox</sup> mice (N = 18, male = 12, female = 6) and PV-Cre; CTNNB1 <sup>flox/flox</sup> mice (N = 10, male = 7, female = 3) were used to test animal behaviors at adulthood (P60) (<xref ref-type="bibr" rid="ddw131-B71">71</xref>). The mice were kept in their cages and acclimated to the behavior testing room 1 h before each test. We recorded each trial with an EthoVision XT video tracking system and software (Noldus).</p>
</sec>
<sec>
<title>Open field test</title>
<p>The test was conducted as described in (<xref ref-type="bibr" rid="ddw131-B46">46</xref>) with modifications. Briefly, each individual mouse was randomly placed at one corner of an opaque, open acrylic box (40×40×40 cm) in a brightly lit room. Video camera recorded horizontal movement of the mouse for 5 min. Total distance traveled, duration and entry frequency in the center (13.3 × 13.3 cm), as well as the latency to the center region, were measured by EthoVision XT software. The open field apparatus was cleaned with 70% ethanol between each trial.</p>
</sec>
<sec>
<title>Elevated Plus Maze test</title>
<p>The test was performed as reported in (<xref ref-type="bibr" rid="ddw131-B39">39</xref>). The maze is a four-armed acrylic platform with a plus shape. The platform is elevated 50 cm above the ground, and two of the arms (5 × 25 cm) were enclosed with high walls, and the other two arms were open. Each mouse was placed into the crossing region (5 × 5 cm) of open and closed arms. The arms entry frequency, latency, duration and distance traveled were measured time spent in the closed and open arms were measured by EthoVision XT video tracking system. The plus maze apparatus was cleaned with 70% ethanol between each trial.</p>
</sec>
<sec>
<title>Novel Object Recognition test</title>
<p>In this test, mice were at first allowed free exploration for 5 min to acclimate with the testing environment in the open field arena. After the habituation session, mice interacted with two identical objects for 5 min. At 1 h after the habituation, the novel object 1 replaced one of the familiar objects. After 24 h, another novel object replaced the novel object 1. The amount of time mice spent with each object was measured by EthoVision XT to test the short- and long-term memory. Three groups of objects were with different shape, material and color, and randomly selected to serve as familiar objects or novel objects. The testing box was cleaned with 70% ethanol between each trial.</p>
</sec>
<sec>
<title>Social interaction test</title>
<p>The SIT was performed as reported with modifications (<xref ref-type="bibr" rid="ddw131-B72">72</xref>). All the mice were single housed for 1 week before the tests. Mice were allowed to habituate with the three-chamber (each 20 × 40 × 20 (h) cm) box with two empty steel wire pencil cups (diameter 7 cm, height 10 cm) placed in center of the left or right chamber for 10 min. After habituation, one gender-matched wild-type mouse was placed in one cup. The wild-type mouse has never been exposed to the test mouse. The tested mouse was allowed to interact with either the empty cup or the cup with mouse for 10 min. At the other 10-min session, a stranger mouse was placed in the empty cup to test social memory. The frequency and time spent interacting with mouse or the empty cup were measured manually. Attempting to climb over or behind the cups was not recorded as an interaction. The testing box was cleaned with 70% ethanol between each trial.</p>
</sec>
<sec>
<title>Morris water maze</title>
<p>The MWM was done as reported in (<xref ref-type="bibr" rid="ddw131-B73">73</xref>) with a period of 5 days, which included four training sessions and one test session. A transparent platform with a diameter of 10 cm was placed in the center of one quadrant of the pool (diameter 150 cm). The top of the platform was placed 2 cm below the water surface. Three other quadrants were labeled with different sign using color tapes for providing mice position cues. Nontoxic white watercolor paint was mixed into the water until the platform was no longer visible.</p>
<p>On training days, each mouse was placed into a randomly selected quadrant of the pool (a random number generator provided a number from one to four). If the mouse did not find the platform within 60 s, it was guided there by hand and allowed to stay there for 15 s. This was repeated three times daily for all the mice. On the testing day, the platform was removed and a circular platform zone was marked in the EthoVision software. The mice were individually placed into the pool and allowed to search for the platform. The times spent in the platform zone, as well as three larger circles concentric to the zone, were measured manually from the recorded videos. Quadrant duration and enter frequency were measured by EthoVision TX. All data are shown as mean ± SEM and analyzed by Student’s two-tailed, unpaired <italic>t</italic>-test.</p>
</sec>
<sec>
<title>Grooming test</title>
<p>This test was used to score the repetitive behaviors (<xref ref-type="bibr" rid="ddw131-B74">74</xref>). Each mouse was misted with a spray of distilled water towards to its face and placed into an empty cage without bedding. The animals were filmed for 25 min each. Accumulated grooming time was measured manually from the video. The first 5 min were excluded from the analysis because the variations in grooming duration during that time seemed largely dependent on the amount of water with which the mouse had been misted.</p>
</sec>
<sec>
<title>Marble burying test</title>
<p>This test was performed as reported in (<xref ref-type="bibr" rid="ddw131-B75">75</xref>). Each mouse was placed into a new cage with 3 cm of bedding and five rows of four marbles on the surface of bedding. Leaving the mice in the testing cages for 10 min, we counted the number of marble buried and measured the latency to the first bury. All data are shown as mean ± SEM and analyzed by Mann-Whitney U test.</p>
</sec>
<sec>
<title>Tail suspension test</title>
<p>Each mouse was secured to a horizontal rod about 60 cm above the floor using the end of its tail. The mouse was recorded for 5 min. Immobility time (when the mouse did not curl, move its paws, or swing across its vertical axis) (<xref ref-type="bibr" rid="ddw131-B76">76</xref>) was measured manually from the video with a stopwatch.</p>
</sec>
<sec>
<title>Rotarod test</title>
<p>This test was done to exclude the possibility of motor deficits in Cre-positive mice that may result in misleading behavior test results (<xref ref-type="bibr" rid="ddw131-B77">77</xref>). Each mouse was placed on the apparatus at four revolutions per minute (RPM). The speed accelerates from 4 RPM to a max of 40 RPM in 5 min, and the maximum speed is maintained for 5 min. We recorded the falling time of each mouse, and repeat the procedure three times per day for 3 days. On the eighth day, mice were tested with the same procedure. The rotarod apparatus was cleaned with 70% ethanol between each trial.</p>
</sec>
<sec>
<title>Nest building test</title>
<p>This test was performed as described in (<xref ref-type="bibr" rid="ddw131-B78">78</xref>). Single-housed mice were transferred to new cages with 2 g nestlet in each cage. Assess the nests after 1, 3, and 24 h on a rating scale of 1–5. Scores were analyzed using Kruskal-Wallis ANOVA.</p>
</sec>
<sec>
<title>Fear conditioning and extinction test</title>
<p>In the training session, each mouse was habituated in the fear conditioning apparatus for 5 min. After the habituation, the mouse in the testing chamber will receive a 2-s, 0.55-mA foot shock every 80 s (<xref ref-type="bibr" rid="ddw131-B79">79</xref>). The mouse was removed immediately after the third shock. During the contextual testing, the freezing behavior of each mouse was recorded in the testing chamber every 24 h until reaching the significant difference between two groups.</p>
</sec>
<sec>
<title>Statistical Analysis</title>
<p>Data were analyzed using Excel and SPSS software and are expressed as means ± SEM. Significances between the experimental group and control group were analyzed by Student’s <italic>t</italic>-test and ANOVA.</p>
</sec>
</sec>
<sec sec-type="supplementary-material"><title>Supplementary Material</title><p><ext-link ext-link-type="uri" xlink:href="http://hmg.oxfordjournals.org/lookup/suppl/doi:10.1093/hmg/ddw131/-/DC1">Supplementary Material</ext-link> is available at <italic>HMG</italic> online.</p>
<supplementary-material content-type="local-data" id="PMC_1">
<caption>
<title>Supplementary Data</title>
</caption>
<media mime-subtype="html" mimetype="text" xlink:href="supp_25_13_2738__index.html"></media>
<media mime-subtype="x-zip-compressed" mimetype="application" xlink:href="supp_ddw131_suppl_data.zip" xlink:role="associated-file"></media>
</supplementary-material>
<supplementary-material content-type="local-data" id="PMC_2">
<caption>
<title>Supplementary Data</title>
</caption>
<media mime-subtype="html" mimetype="text" xlink:href="supp_25_13_2738_v2_index.html"></media>
<media mime-subtype="x-zip-compressed" mimetype="application" xlink:href="supp_ddw131_Suppl.zip" xlink:role="associated-file"></media>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>We thank Ms Siying Zhu and Dr Bernhard Luscher, Dr Timothy Jegla and Dr Gong Chen for the technical support. Dr Yingwei Mao is a receipt of NARSAD Young Investigator Award and American Heart Scientist Development Award. We thank Gary Howard for suggestions.</p>
<p><italic>Conflict of Interest statement</italic>. None declared.</p>
<sec>
<title>Funding</title>
<p>Funding to pay the Open Access publication charges for this article was provided by <funding-source>Research Foundation of National University of Defense Technology</funding-source> to Dr. Long Liu, <award-id>JC-14-02-01</award-id>.</p>
</sec>
</ack>
<ref-list>
<title>References</title>
<ref id="ddw131-B1">
<label>1</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>D.L.</given-names></name><name><surname>Goldstein</surname><given-names>G.</given-names></name><name><surname>Minshew</surname><given-names>N.J.</given-names></name></person-group> (<year>2006</year>) 
<article-title>Neuropsychologic functioning in children with autism: further evidence for disordered complex information-processing</article-title>. <source/>Child Neuropsychol., <volume>12</volume>, <fpage>279</fpage>–<lpage>298</lpage>.<pub-id pub-id-type="pmid">16911973</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B2">
<label>2</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Steensel</surname><given-names>F.J.</given-names></name><name><surname>Bogels</surname><given-names>S.M.</given-names></name><name><surname>Perrin</surname><given-names>S.</given-names></name></person-group> (<year>2011</year>) 
<article-title>Anxiety disorders in children and adolescents with autistic spectrum disorders: a meta-analysis</article-title>. <source/>Clin. Child Fam. Psychol. Rev., <volume>14</volume>, <fpage>302</fpage>–<lpage>317</lpage>.<pub-id pub-id-type="pmid">21735077</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B3">
<label>3</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>D.L.</given-names></name><name><surname>Goldstein</surname><given-names>G.</given-names></name><name><surname>Minshew</surname><given-names>N.J.</given-names></name></person-group> (<year>2006</year>) 
<article-title>The profile of memory function in children with autism</article-title>. <source/>Neuropsychology, <volume>20</volume>, <fpage>21</fpage>–<lpage>29</lpage>.<pub-id pub-id-type="pmid">16460219</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B4">
<label>4</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miles</surname><given-names>J.H.</given-names></name></person-group> (<year>2011</year>) 
<article-title>Autism spectrum disorders–a genetics review</article-title>. <source/>Genet. Med., <volume>13</volume>, <fpage>278</fpage>–<lpage>294</lpage>.<pub-id pub-id-type="pmid">21358411</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B5">
<label>5</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanders</surname><given-names>S.J.</given-names></name><name><surname>He</surname><given-names>X.</given-names></name><name><surname>Willsey</surname><given-names>A.J.</given-names></name><name><surname>Ercan-Sencicek</surname><given-names>A.G.</given-names></name><name><surname>Samocha</surname><given-names>K.E.</given-names></name><name><surname>Cicek</surname><given-names>A.E.</given-names></name><name><surname>Murtha</surname><given-names>M.T.</given-names></name><name><surname>Bal</surname><given-names>V.H.</given-names></name><name><surname>Bishop</surname><given-names>S.L.</given-names></name><name><surname>Dong</surname><given-names>S</given-names></name></person-group>
<etal></etal> (<year>2015</year>) 
<article-title>Insights into autism spectrum disorder genomic architecture and biology from 71 risk loci</article-title>. <source/>Neuron, <volume>87</volume>, <fpage>1215</fpage>–<lpage>1233</lpage>.<pub-id pub-id-type="pmid">26402605</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B6">
<label>6</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Roak</surname><given-names>B.J.</given-names></name><name><surname>Vives</surname><given-names>L.</given-names></name><name><surname>Girirajan</surname><given-names>S.</given-names></name><name><surname>Karakoc</surname><given-names>E.</given-names></name><name><surname>Krumm</surname><given-names>N.</given-names></name><name><surname>Coe</surname><given-names>B.P.</given-names></name><name><surname>Levy</surname><given-names>R.</given-names></name><name><surname>Ko</surname><given-names>A.</given-names></name><name><surname>Lee</surname><given-names>C.</given-names></name><name><surname>Smith</surname><given-names>J.D</given-names></name></person-group>
<etal></etal> (<year>2012</year>) 
<article-title>Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations</article-title>. <source/>Nature, <volume>485</volume>, <fpage>246</fpage>–<lpage>250</lpage>.<pub-id pub-id-type="pmid">22495309</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B7">
<label>7</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brembeck</surname><given-names>F.H.</given-names></name><name><surname>Rosario</surname><given-names>M.</given-names></name><name><surname>Birchmeier</surname><given-names>W.</given-names></name></person-group> (<year>2006</year>) 
<article-title>Balancing cell adhesion and Wnt signaling, the key role of beta-catenin</article-title>. <source/>Curr. Opin. Genet. Dev., <volume>16</volume>, <fpage>51</fpage>–<lpage>59</lpage>.<pub-id pub-id-type="pmid">16377174</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B8">
<label>8</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haegel</surname><given-names>H.</given-names></name><name><surname>Larue</surname><given-names>L.</given-names></name><name><surname>Ohsugi</surname><given-names>M.</given-names></name><name><surname>Fedorov</surname><given-names>L.</given-names></name><name><surname>Herrenknecht</surname><given-names>K.</given-names></name><name><surname>Kemler</surname><given-names>R.</given-names></name></person-group> (<year>1995</year>) 
<article-title>Lack of beta-catenin affects mouse development at gastrulation</article-title>. <source/>Development, <volume>121</volume>, <fpage>3529</fpage>–<lpage>3537</lpage>.<pub-id pub-id-type="pmid">8582267</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B9">
<label>9</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Ligt</surname><given-names>J.</given-names></name><name><surname>Willemsen</surname><given-names>M.H.</given-names></name><name><surname>van Bon</surname><given-names>B.W.</given-names></name><name><surname>Kleefstra</surname><given-names>T.</given-names></name><name><surname>Yntema</surname><given-names>H.G.</given-names></name><name><surname>Kroes</surname><given-names>T.</given-names></name><name><surname>Vulto-van Silfhout</surname><given-names>A.T.</given-names></name><name><surname>Koolen</surname><given-names>D.A.</given-names></name><name><surname>de Vries</surname><given-names>P.</given-names></name><name><surname>Gilissen</surname><given-names>C</given-names></name></person-group>
<etal></etal> (<year>2012</year>) 
<article-title>Diagnostic exome sequencing in persons with severe intellectual disability</article-title>. <source/>N. Engl. J. Med., <volume>367</volume>, <fpage>1921</fpage>–<lpage>1929</lpage>.<pub-id pub-id-type="pmid">23033978</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B10">
<label>10</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chenn</surname><given-names>A.</given-names></name><name><surname>Walsh</surname><given-names>C.A.</given-names></name></person-group> (<year>2002</year>) 
<article-title>Regulation of cerebral cortical size by control of cell cycle exit in neural precursors</article-title>. <source/>Science, <volume>297</volume>, <fpage>365</fpage>–<lpage>369</lpage>.<pub-id pub-id-type="pmid">12130776</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B11">
<label>11</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zechner</surname><given-names>D.</given-names></name><name><surname>Fujita</surname><given-names>Y.</given-names></name><name><surname>Hulsken</surname><given-names>J.</given-names></name><name><surname>Muller</surname><given-names>T.</given-names></name><name><surname>Walther</surname><given-names>I.</given-names></name><name><surname>Taketo</surname><given-names>M.M.</given-names></name><name><surname>Crenshaw</surname><given-names>E.B.</given-names><suffix>3rd</suffix></name><name><surname>Birchmeier</surname><given-names>W.</given-names></name><name><surname>Birchmeier</surname><given-names>C.</given-names></name></person-group> (<year>2003</year>) 
<article-title>beta-Catenin signals regulate cell growth and the balance between progenitor cell expansion and differentiation in the nervous system</article-title>. <source/>Dev. Biol., <volume>258</volume>, <fpage>406</fpage>–<lpage>418</lpage>.<pub-id pub-id-type="pmid">12798297</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B12">
<label>12</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brault</surname><given-names>V.</given-names></name><name><surname>Moore</surname><given-names>R.</given-names></name><name><surname>Kutsch</surname><given-names>S.</given-names></name><name><surname>Ishibashi</surname><given-names>M.</given-names></name><name><surname>Rowitch</surname><given-names>D.H.</given-names></name><name><surname>McMahon</surname><given-names>A.P.</given-names></name><name><surname>Sommer</surname><given-names>L.</given-names></name><name><surname>Boussadia</surname><given-names>O.</given-names></name><name><surname>Kemler</surname><given-names>R.</given-names></name></person-group> (<year>2001</year>) 
<article-title>Inactivation of the beta-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development</article-title>. <source/>Development, <volume>128</volume>, <fpage>1253</fpage>–<lpage>1264</lpage>.<pub-id pub-id-type="pmid">11262227</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B13">
<label>13</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>X.</given-names></name><name><surname>Malenka</surname><given-names>R.C.</given-names></name></person-group> (<year>2003</year>) 
<article-title>Beta-catenin is critical for dendritic morphogenesis</article-title>. <source/>Nat. Neurosci., <volume>6</volume>, <fpage>1169</fpage>–<lpage>1177</lpage>.<pub-id pub-id-type="pmid">14528308</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B14">
<label>14</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>Z.J.</given-names></name><name><surname>Peng</surname><given-names>Y.</given-names></name><name><surname>Song</surname><given-names>H.L.</given-names></name><name><surname>Zheng</surname><given-names>J.J.</given-names></name><name><surname>Yu</surname><given-names>X.</given-names></name></person-group> (<year>2010</year>) 
<article-title>N-cadherin-dependent neuron-neuron interaction is required for the maintenance of activity-induced dendrite growth</article-title>. <source/>Proc. Natl. Acad. Sci. U S A, <volume>107</volume>, <fpage>9873</fpage>–<lpage>9878</lpage>.<pub-id pub-id-type="pmid">20457910</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B15">
<label>15</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murase</surname><given-names>S.</given-names></name><name><surname>Mosser</surname><given-names>E.</given-names></name><name><surname>Schuman</surname><given-names>E.M.</given-names></name></person-group> (<year>2002</year>) 
<article-title>Depolarization drives beta-Catenin into neuronal spines promoting changes in synaptic structure and function</article-title>. <source/>Neuron, <volume>35</volume>, <fpage>91</fpage>–<lpage>105</lpage>.<pub-id pub-id-type="pmid">12123611</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B16">
<label>16</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bian</surname><given-names>W.J.</given-names></name><name><surname>Miao</surname><given-names>W.Y.</given-names></name><name><surname>He</surname><given-names>S.J.</given-names></name><name><surname>Qiu</surname><given-names>Z.</given-names></name><name><surname>Yu</surname><given-names>X.</given-names></name></person-group> (<year>2015</year>) 
<article-title>Coordinated Spine Pruning and Maturation Mediated by Inter-Spine Competition for Cadherin/Catenin Complexes</article-title>. <source/>Cell, <volume>162</volume>, <fpage>808</fpage>–<lpage>822</lpage>.<pub-id pub-id-type="pmid">26255771</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B17">
<label>17</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>Y.R.</given-names></name><name><surname>He</surname><given-names>S.</given-names></name><name><surname>Marie</surname><given-names>H.</given-names></name><name><surname>Zeng</surname><given-names>S.Y.</given-names></name><name><surname>Ma</surname><given-names>J.</given-names></name><name><surname>Tan</surname><given-names>Z.J.</given-names></name><name><surname>Lee</surname><given-names>S.Y.</given-names></name><name><surname>Malenka</surname><given-names>R.C.</given-names></name><name><surname>Yu</surname><given-names>X.</given-names></name></person-group> (<year>2009</year>) 
<article-title>Coordinated changes in dendritic arborization and synaptic strength during neural circuit development</article-title>. <source/>Neuron, <volume>61</volume>, <fpage>71</fpage>–<lpage>84</lpage>.<pub-id pub-id-type="pmid">19146814</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B18">
<label>18</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okuda</surname><given-names>T.</given-names></name><name><surname>Yu</surname><given-names>L.M.</given-names></name><name><surname>Cingolani</surname><given-names>L.A.</given-names></name><name><surname>Kemler</surname><given-names>R.</given-names></name><name><surname>Goda</surname><given-names>Y.</given-names></name></person-group> (<year>2007</year>) 
<article-title>beta-Catenin regulates excitatory postsynaptic strength at hippocampal synapses</article-title>. <source/>Proc. Natl. Acad. Sci. U S A, <volume>104</volume>, <fpage>13479</fpage>–<lpage>13484</lpage>.<pub-id pub-id-type="pmid">17679699</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B19">
<label>19</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>A.M.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Tai</surname><given-names>H.C.</given-names></name><name><surname>Schuman</surname><given-names>E.M.</given-names></name></person-group> (<year>2013</year>) 
<article-title>Axonal translation of beta-catenin regulates synaptic vesicle dynamics</article-title>. <source/>J. Neurosci., <volume>33</volume>, <fpage>5584</fpage>–<lpage>5589</lpage>.<pub-id pub-id-type="pmid">23536073</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B20">
<label>20</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bamji</surname><given-names>S.X.</given-names></name><name><surname>Shimazu</surname><given-names>K.</given-names></name><name><surname>Kimes</surname><given-names>N.</given-names></name><name><surname>Huelsken</surname><given-names>J.</given-names></name><name><surname>Birchmeier</surname><given-names>W.</given-names></name><name><surname>Lu</surname><given-names>B.</given-names></name><name><surname>Reichardt</surname><given-names>L.F.</given-names></name></person-group> (<year>2003</year>) 
<article-title>Role of beta-catenin in synaptic vesicle localization and presynaptic assembly</article-title>. <source/>Neuron, <volume>40</volume>, <fpage>719</fpage>–<lpage>731</lpage>.<pub-id pub-id-type="pmid">14622577</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B21">
<label>21</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bamji</surname><given-names>S.X.</given-names></name><name><surname>Rico</surname><given-names>B.</given-names></name><name><surname>Kimes</surname><given-names>N.</given-names></name><name><surname>Reichardt</surname><given-names>L.F.</given-names></name></person-group> (<year>2006</year>) 
<article-title>BDNF mobilizes synaptic vesicles and enhances synapse formation by disrupting cadherin-beta-catenin interactions</article-title>. <source/>J. Cell. Biol., <volume>174</volume>, <fpage>289</fpage>–<lpage>299</lpage>.<pub-id pub-id-type="pmid">16831887</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B22">
<label>22</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maguschak</surname><given-names>K.A.</given-names></name><name><surname>Ressler</surname><given-names>K.J.</given-names></name></person-group> (<year>2008</year>) 
<article-title>Beta-catenin is required for memory consolidation</article-title>. <source/>Nat. Neurosci., <volume>11</volume>, <fpage>1319</fpage>–<lpage>1326</lpage>.<pub-id pub-id-type="pmid">18820693</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B23">
<label>23</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tucci</surname><given-names>V.</given-names></name><name><surname>Kleefstra</surname><given-names>T.</given-names></name><name><surname>Hardy</surname><given-names>A.</given-names></name><name><surname>Heise</surname><given-names>I.</given-names></name><name><surname>Maggi</surname><given-names>S.</given-names></name><name><surname>Willemsen</surname><given-names>M.H.</given-names></name><name><surname>Hilton</surname><given-names>H.</given-names></name><name><surname>Esapa</surname><given-names>C.</given-names></name><name><surname>Simon</surname><given-names>M.</given-names></name><name><surname>Buenavista</surname><given-names>M.T</given-names></name></person-group>, <etal></etal> (<year>2014</year>) 
<article-title>Dominant beta-catenin mutations cause intellectual disability with recognizable syndromic features</article-title>. <source/>J. Clin. Invest., <volume>124</volume>, <fpage>1468</fpage>–<lpage>1482</lpage>.<pub-id pub-id-type="pmid">24614104</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B24">
<label>24</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mills</surname><given-names>F.</given-names></name><name><surname>Bartlett</surname><given-names>T.E.</given-names></name><name><surname>Dissing-Olesen</surname><given-names>L.</given-names></name><name><surname>Wisniewska</surname><given-names>M.B.</given-names></name><name><surname>Kuznicki</surname><given-names>J.</given-names></name><name><surname>Macvicar</surname><given-names>B.A.</given-names></name><name><surname>Wang</surname><given-names>Y.T.</given-names></name><name><surname>Bamji</surname><given-names>S.X.</given-names></name></person-group> (<year>2014</year>) 
<article-title>Cognitive flexibility and long-term depression (LTD) are impaired following beta-catenin stabilization in vivo</article-title>. <source/>Proc. Natl. Acad. Sci. U S A, <volume>111</volume>, <fpage>8631</fpage>–<lpage>8636</lpage>.<pub-id pub-id-type="pmid">24912177</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B25">
<label>25</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gould</surname><given-names>T.D.</given-names></name><name><surname>O'Donnell</surname><given-names>K.C.</given-names></name><name><surname>Picchini</surname><given-names>A.M.</given-names></name><name><surname>Dow</surname><given-names>E.R.</given-names></name><name><surname>Chen</surname><given-names>G.</given-names></name><name><surname>Manji</surname><given-names>H.K.</given-names></name></person-group> (<year>2008</year>) 
<article-title>Generation and behavioral characterization of beta-catenin forebrain-specific conditional knock-out mice</article-title>. <source/>Behav. Brain Res., <volume>189</volume>, <fpage>117</fpage>–<lpage>125</lpage>.<pub-id pub-id-type="pmid">18299155</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B26">
<label>26</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohn</surname><given-names>J.L.</given-names></name><name><surname>Alexander</surname><given-names>J.</given-names></name><name><surname>Pirone</surname><given-names>A.</given-names></name><name><surname>Palka</surname><given-names>C.D.</given-names></name><name><surname>Lee</surname><given-names>S.Y.</given-names></name><name><surname>Mebane</surname><given-names>L.</given-names></name><name><surname>Haydon</surname><given-names>P.G.</given-names></name><name><surname>Jacob</surname><given-names>M.H.</given-names></name></person-group> (<year>2014</year>) 
<article-title>Adenomatous polyposis coli protein deletion leads to cognitive and autism-like disabilities</article-title>. <source/>Mol. Psychiatry, <volume>19</volume>, <fpage>1133</fpage>–<lpage>1142</lpage>.<pub-id pub-id-type="pmid">24934177</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B27">
<label>27</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname><given-names>C.H.</given-names></name><name><surname>Luikart</surname><given-names>B.W.</given-names></name><name><surname>Powell</surname><given-names>C.M.</given-names></name><name><surname>Zhou</surname><given-names>J.</given-names></name><name><surname>Matheny</surname><given-names>S.A.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Baker</surname><given-names>S.J.</given-names></name><name><surname>Parada</surname><given-names>L.F.</given-names></name></person-group> (<year>2006</year>) 
<article-title>Pten regulates neuronal arborization and social interaction in mice</article-title>. <source/>Neuron, <volume>50</volume>, <fpage>377</fpage>–<lpage>388</lpage>.<pub-id pub-id-type="pmid">16675393</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B28">
<label>28</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>A.</given-names></name><name><surname>Kasai</surname><given-names>S.</given-names></name><name><surname>Kobayashi</surname><given-names>T.</given-names></name><name><surname>Takamatsu</surname><given-names>Y.</given-names></name><name><surname>Hino</surname><given-names>O.</given-names></name><name><surname>Ikeda</surname><given-names>K.</given-names></name><name><surname>Mizuguchi</surname><given-names>M.</given-names></name></person-group> (<year>2012</year>) 
<article-title>Rapamycin reverses impaired social interaction in mouse models of tuberous sclerosis complex</article-title>. <source/>Nat. Commun., <volume>3</volume>, <fpage>1292.</fpage><pub-id pub-id-type="pmid">23250422</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B29">
<label>29</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>H.</given-names></name><name><surname>Gan</surname><given-names>J.</given-names></name><name><surname>Jonas</surname><given-names>P.</given-names></name></person-group> (<year>2014</year>) 
<article-title>Interneurons. Fast-spiking, parvalbumin(+) GABAergic interneurons: from cellular design to microcircuit function</article-title>. <source/>Science, <volume>345</volume>, <fpage>1255263.</fpage><pub-id pub-id-type="pmid">25082707</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B30">
<label>30</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawrence</surname><given-names>Y.A.</given-names></name><name><surname>Kemper</surname><given-names>T.L.</given-names></name><name><surname>Bauman</surname><given-names>M.L.</given-names></name><name><surname>Blatt</surname><given-names>G.J.</given-names></name></person-group> (<year>2010</year>) 
<article-title>Parvalbumin-, calbindin-, and calretinin-immunoreactive hippocampal interneuron density in autism</article-title>. <source/>Acta Neurol. Scand., <volume>121</volume>, <fpage>99</fpage>–<lpage>108</lpage>.<pub-id pub-id-type="pmid">19719810</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B31">
<label>31</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blatt</surname><given-names>G.J.</given-names></name><name><surname>Fatemi</surname><given-names>S.H.</given-names></name></person-group> (<year>2011</year>) 
<article-title>Alterations in GABAergic biomarkers in the autism brain: research findings and clinical implications</article-title>. <source/>Anat. Rec. (Hoboken), <volume>294</volume>, <fpage>1646</fpage>–<lpage>1652</lpage>.<pub-id pub-id-type="pmid">21901839</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B32">
<label>32</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yip</surname><given-names>J.</given-names></name><name><surname>Soghomonian</surname><given-names>J.J.</given-names></name><name><surname>Blatt</surname><given-names>G.J.</given-names></name></person-group> (<year>2008</year>) 
<article-title>Increased GAD67 mRNA expression in cerebellar interneurons in autism: implications for Purkinje cell dysfunction</article-title>. <source/>J. Neurosci. Res., <volume>86</volume>, <fpage>525</fpage>–<lpage>530</lpage>.<pub-id pub-id-type="pmid">17918742</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B33">
<label>33</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yip</surname><given-names>J.</given-names></name><name><surname>Soghomonian</surname><given-names>J.J.</given-names></name><name><surname>Blatt</surname><given-names>G.J.</given-names></name></person-group> (<year>2009</year>) 
<article-title>Decreased GAD65 mRNA levels in select subpopulations of neurons in the cerebellar dentate nuclei in autism: an in situ hybridization study</article-title>. <source/>Autism Res., <volume>2</volume>, <fpage>50</fpage>–<lpage>59</lpage>.<pub-id pub-id-type="pmid">19358307</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B34">
<label>34</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gogolla</surname><given-names>N.</given-names></name><name><surname>Leblanc</surname><given-names>J.J.</given-names></name><name><surname>Quast</surname><given-names>K.B.</given-names></name><name><surname>Sudhof</surname><given-names>T.C.</given-names></name><name><surname>Fagiolini</surname><given-names>M.</given-names></name><name><surname>Hensch</surname><given-names>T.K.</given-names></name></person-group> (<year>2009</year>) 
<article-title>Common circuit defect of excitatory-inhibitory balance in mouse models of autism</article-title>. <source/>J. Neurodev. Disord., <volume>1</volume>, <fpage>172</fpage>–<lpage>181</lpage>.<pub-id pub-id-type="pmid">20664807</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B35">
<label>35</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Councill</surname><given-names>J.H.</given-names></name><name><surname>Tucker</surname><given-names>E.S.</given-names></name><name><surname>Haskell</surname><given-names>G.T.</given-names></name><name><surname>Maynard</surname><given-names>T.M.</given-names></name><name><surname>Meechan</surname><given-names>D.W.</given-names></name><name><surname>Hamer</surname><given-names>R.M.</given-names></name><name><surname>Lieberman</surname><given-names>J.A.</given-names></name><name><surname>LaMantia</surname><given-names>A.S.</given-names></name></person-group> (<year>2006</year>) 
<article-title>Limited influence of olanzapine on adult forebrain neural precursors in vitro</article-title>. <source/>Neuroscience, <volume>140</volume>, <fpage>111</fpage>–<lpage>122</lpage>.<pub-id pub-id-type="pmid">16564641</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B36">
<label>36</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wohr</surname><given-names>M.</given-names></name><name><surname>Orduz</surname><given-names>D.</given-names></name><name><surname>Gregory</surname><given-names>P.</given-names></name><name><surname>Moreno</surname><given-names>H.</given-names></name><name><surname>Khan</surname><given-names>U.</given-names></name><name><surname>Vorckel</surname><given-names>K.J.</given-names></name><name><surname>Wolfer</surname><given-names>D.P.</given-names></name><name><surname>Welzl</surname><given-names>H.</given-names></name><name><surname>Gall</surname><given-names>D.</given-names></name><name><surname>Schiffmann</surname><given-names>S.N</given-names></name></person-group>
<etal></etal> (<year>2015</year>) 
<article-title>Lack of parvalbumin in mice leads to behavioral deficits relevant to all human autism core symptoms and related neural morphofunctional abnormalities</article-title>. <source/>Transl. Psychiatry, <volume>5</volume>, <fpage>e525.</fpage><pub-id pub-id-type="pmid">25756808</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B37">
<label>37</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marin</surname><given-names>O.</given-names></name></person-group> (<year>2012</year>) 
<article-title>Interneuron dysfunction in psychiatric disorders</article-title>. <source/>Nat. Rev. Neurosci., <volume>13</volume>, <fpage>107</fpage>–<lpage>120</lpage>.<pub-id pub-id-type="pmid">22251963</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B38">
<label>38</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davila</surname><given-names>J.C.</given-names></name><name><surname>Real</surname><given-names>M.A.</given-names></name><name><surname>Olmos</surname><given-names>L.</given-names></name><name><surname>Legaz</surname><given-names>I.</given-names></name><name><surname>Medina</surname><given-names>L.</given-names></name><name><surname>Guirado</surname><given-names>S.</given-names></name></person-group> (<year>2005</year>) 
<article-title>Embryonic and postnatal development of GABA, calbindin, calretinin, and parvalbumin in the mouse claustral complex</article-title>. <source/>J. Comp. Neurol., <volume>481</volume>, <fpage>42</fpage>–<lpage>57</lpage>.<pub-id pub-id-type="pmid">15558732</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B39">
<label>39</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walf</surname><given-names>A.A.</given-names></name><name><surname>Frye</surname><given-names>C.A.</given-names></name></person-group> (<year>2007</year>) 
<article-title>The use of the elevated plus maze as an assay of anxiety-related behavior in rodents</article-title>. <source/>Nat. Protoc., <volume>2</volume>, <fpage>322</fpage>–<lpage>328</lpage>.<pub-id pub-id-type="pmid">17406592</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B40">
<label>40</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeda</surname><given-names>H.</given-names></name><name><surname>Tsuji</surname><given-names>M.</given-names></name><name><surname>Matsumiya</surname><given-names>T.</given-names></name></person-group> (<year>1998</year>) 
<article-title>Changes in head-dipping behavior in the hole-board test reflect the anxiogenic and/or anxiolytic state in mice</article-title>. <source/>Eur. J. Pharmacol., <volume>350</volume>, <fpage>21</fpage>–<lpage>29</lpage>.<pub-id pub-id-type="pmid">9683010</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B41">
<label>41</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steru</surname><given-names>L.</given-names></name><name><surname>Chermat</surname><given-names>R.</given-names></name><name><surname>Thierry</surname><given-names>B.</given-names></name><name><surname>Simon</surname><given-names>P.</given-names></name></person-group> (<year>1985</year>) 
<article-title>The tail suspension test: a new method for screening antidepressants in mice</article-title>. <source/>Psychopharmacology (Berl), <volume>85</volume>, <fpage>367</fpage>–<lpage>370</lpage>.<pub-id pub-id-type="pmid">3923523</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B42">
<label>42</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donato</surname><given-names>F.</given-names></name><name><surname>Rompani</surname><given-names>S.B.</given-names></name><name><surname>Caroni</surname><given-names>P.</given-names></name></person-group> (<year>2013</year>) 
<article-title>Parvalbumin-expressing basket-cell network plasticity induced by experience regulates adult learning</article-title>. <source/>Nature, <volume>504</volume>, <fpage>272</fpage>–<lpage>276</lpage>.<pub-id pub-id-type="pmid">24336286</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B43">
<label>43</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Courtin</surname><given-names>J.</given-names></name><name><surname>Chaudun</surname><given-names>F.</given-names></name><name><surname>Rozeske</surname><given-names>R.R.</given-names></name><name><surname>Karalis</surname><given-names>N.</given-names></name><name><surname>Gonzalez-Campo</surname><given-names>C.</given-names></name><name><surname>Wurtz</surname><given-names>H.</given-names></name><name><surname>Abdi</surname><given-names>A.</given-names></name><name><surname>Baufreton</surname><given-names>J.</given-names></name><name><surname>Bienvenu</surname><given-names>T.C.</given-names></name><name><surname>Herry</surname><given-names>C.</given-names></name></person-group> (<year>2014</year>) 
<article-title>Prefrontal parvalbumin interneurons shape neuronal activity to drive fear expression</article-title>. <source/>Nature, <volume>505</volume>, <fpage>92</fpage>–<lpage>96</lpage>.<pub-id pub-id-type="pmid">24256726</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B44">
<label>44</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pitts</surname><given-names>M.W.</given-names></name><name><surname>Raman</surname><given-names>A.V.</given-names></name><name><surname>Hashimoto</surname><given-names>A.C.</given-names></name><name><surname>Todorovic</surname><given-names>C.</given-names></name><name><surname>Nichols</surname><given-names>R.A.</given-names></name><name><surname>Berry</surname><given-names>M.J.</given-names></name></person-group> (<year>2012</year>) 
<article-title>Deletion of selenoprotein P results in impaired function of parvalbumin interneurons and alterations in fear learning and sensorimotor gating</article-title>. <source/>Neuroscience, <volume>208</volume>, <fpage>58</fpage>–<lpage>68</lpage>.<pub-id pub-id-type="pmid">22640876</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B45">
<label>45</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tabuchi</surname><given-names>K.</given-names></name><name><surname>Blundell</surname><given-names>J.</given-names></name><name><surname>Etherton</surname><given-names>M.R.</given-names></name><name><surname>Hammer</surname><given-names>R.E.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Powell</surname><given-names>C.M.</given-names></name><name><surname>Sudhof</surname><given-names>T.C.</given-names></name></person-group> (<year>2007</year>) 
<article-title>A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice</article-title>. <source/>Science, <volume>318</volume>, <fpage>71</fpage>–<lpage>76</lpage>.<pub-id pub-id-type="pmid">17823315</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B46">
<label>46</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>S.</given-names></name><name><surname>Tai</surname><given-names>C.</given-names></name><name><surname>Westenbroek</surname><given-names>R.E.</given-names></name><name><surname>Yu</surname><given-names>F.H.</given-names></name><name><surname>Cheah</surname><given-names>C.S.</given-names></name><name><surname>Potter</surname><given-names>G.B.</given-names></name><name><surname>Rubenstein</surname><given-names>J.L.</given-names></name><name><surname>Scheuer</surname><given-names>T.</given-names></name><name><surname>de la Iglesia</surname><given-names>H.O.</given-names></name><name><surname>Catterall</surname><given-names>W.A.</given-names></name></person-group> (<year>2012</year>) 
<article-title>Autistic-like behaviour in Scn1a+/- mice and rescue by enhanced GABA-mediated neurotransmission</article-title>. <source/>Nature, <volume>489</volume>, <fpage>385</fpage>–<lpage>390</lpage>.<pub-id pub-id-type="pmid">22914087</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B47">
<label>47</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blundell</surname><given-names>J.</given-names></name><name><surname>Blaiss</surname><given-names>C.A.</given-names></name><name><surname>Etherton</surname><given-names>M.R.</given-names></name><name><surname>Espinosa</surname><given-names>F.</given-names></name><name><surname>Tabuchi</surname><given-names>K.</given-names></name><name><surname>Walz</surname><given-names>C.</given-names></name><name><surname>Bolliger</surname><given-names>M.F.</given-names></name><name><surname>Sudhof</surname><given-names>T.C.</given-names></name><name><surname>Powell</surname><given-names>C.M.</given-names></name></person-group> (<year>2010</year>) 
<article-title>Neuroligin-1 deletion results in impaired spatial memory and increased repetitive behavior</article-title>. <source/>J. Neurosci., <volume>30</volume>, <fpage>2115</fpage>–<lpage>2129</lpage>.<pub-id pub-id-type="pmid">20147539</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B48">
<label>48</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moretti</surname><given-names>P.</given-names></name><name><surname>Levenson</surname><given-names>J.M.</given-names></name><name><surname>Battaglia</surname><given-names>F.</given-names></name><name><surname>Atkinson</surname><given-names>R.</given-names></name><name><surname>Teague</surname><given-names>R.</given-names></name><name><surname>Antalffy</surname><given-names>B.</given-names></name><name><surname>Armstrong</surname><given-names>D.</given-names></name><name><surname>Arancio</surname><given-names>O.</given-names></name><name><surname>Sweatt</surname><given-names>J.D.</given-names></name><name><surname>Zoghbi</surname><given-names>H.Y.</given-names></name></person-group> (<year>2006</year>) 
<article-title>Learning and memory and synaptic plasticity are impaired in a mouse model of Rett syndrome</article-title>. <source/>J. Neurosci., <volume>26</volume>, <fpage>319</fpage>–<lpage>327</lpage>.<pub-id pub-id-type="pmid">16399702</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B49">
<label>49</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hung</surname><given-names>A.Y.</given-names></name><name><surname>Futai</surname><given-names>K.</given-names></name><name><surname>Sala</surname><given-names>C.</given-names></name><name><surname>Valtschanoff</surname><given-names>J.G.</given-names></name><name><surname>Ryu</surname><given-names>J.</given-names></name><name><surname>Woodworth</surname><given-names>M.A.</given-names></name><name><surname>Kidd</surname><given-names>F.L.</given-names></name><name><surname>Sung</surname><given-names>C.C.</given-names></name><name><surname>Miyakawa</surname><given-names>T.</given-names></name><name><surname>Bear</surname><given-names>M.F</given-names></name></person-group>, <etal></etal> (<year>2008</year>) 
<article-title>Smaller dendritic spines, weaker synaptic transmission, but enhanced spatial learning in mice lacking Shank1</article-title>. <source/>J. Neurosci., <volume>28</volume>, <fpage>1697</fpage>–<lpage>1708</lpage>.<pub-id pub-id-type="pmid">18272690</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B50">
<label>50</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hedlund</surname><given-names>P.B.</given-names></name><name><surname>Sutcliffe</surname><given-names>J.G.</given-names></name></person-group> (<year>2007</year>) 
<article-title>The 5-HT7 receptor influences stereotypic behavior in a model of obsessive-compulsive disorder</article-title>. <source/>Neurosci. Lett., <volume>414</volume>, <fpage>247</fpage>–<lpage>251</lpage>.<pub-id pub-id-type="pmid">17267119</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B51">
<label>51</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moy</surname><given-names>S.S.</given-names></name><name><surname>Nadler</surname><given-names>J.J.</given-names></name><name><surname>Young</surname><given-names>N.B.</given-names></name><name><surname>Perez</surname><given-names>A.</given-names></name><name><surname>Holloway</surname><given-names>L.P.</given-names></name><name><surname>Barbaro</surname><given-names>R.P.</given-names></name><name><surname>Barbaro</surname><given-names>J.R.</given-names></name><name><surname>Wilson</surname><given-names>L.M.</given-names></name><name><surname>Threadgill</surname><given-names>D.W.</given-names></name><name><surname>Lauder</surname><given-names>J.M</given-names></name></person-group>
<etal></etal> (<year>2007</year>) 
<article-title>Mouse behavioral tasks relevant to autism: phenotypes of 10 inbred strains</article-title>. <source/>Behav. Brain Res., <volume>176</volume>, <fpage>4</fpage>–<lpage>20</lpage>.<pub-id pub-id-type="pmid">16971002</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B52">
<label>52</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deacon</surname><given-names>R.M.</given-names></name><name><surname>Croucher</surname><given-names>A.</given-names></name><name><surname>Rawlins</surname><given-names>J.N.</given-names></name></person-group> (<year>2002</year>) 
<article-title>Hippocampal cytotoxic lesion effects on species-typical behaviours in mice</article-title>. <source/>Behav. Brain Res., <volume>132</volume>, <fpage>203</fpage>–<lpage>213</lpage>.<pub-id pub-id-type="pmid">11997150</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B53">
<label>53</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slotnick</surname><given-names>B.M.</given-names></name><name><surname>Nigrosh</surname><given-names>B.J.</given-names></name></person-group> (<year>1975</year>) 
<article-title>Maternal behavior of mice with cingulate cortical, amygdala, or septal lesions</article-title>. <source/>J. Comp. Physiol. Psychol., <volume>88</volume>, <fpage>118</fpage>–<lpage>127</lpage>.<pub-id pub-id-type="pmid">1168206</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B54">
<label>54</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allsop</surname><given-names>S.A.</given-names></name><name><surname>Vander Weele</surname><given-names>C.M.</given-names></name><name><surname>Wichmann</surname><given-names>R.</given-names></name><name><surname>Tye</surname><given-names>K.M.</given-names></name></person-group> (<year>2014</year>) 
<article-title>Optogenetic insights on the relationship between anxiety-related behaviors and social deficits</article-title>. <source/>Front. Behav. Neurosci., <volume>8</volume>, <fpage>241.</fpage><pub-id pub-id-type="pmid">25076878</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B55">
<label>55</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilcox</surname><given-names>J.A.</given-names></name><name><surname>Tsuang</surname><given-names>M.T.</given-names></name><name><surname>Schnurr</surname><given-names>T.</given-names></name><name><surname>Baida-Fragoso</surname><given-names>N.</given-names></name></person-group> (<year>2003</year>) 
<article-title>Case-control family study of lesser variant traits in autism</article-title>. <source/>Neuropsychobiology, <volume>47</volume>, <fpage>171</fpage>–<lpage>177</lpage>.<pub-id pub-id-type="pmid">12824738</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B56">
<label>56</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dias</surname><given-names>C.</given-names></name><name><surname>Feng</surname><given-names>J.</given-names></name><name><surname>Sun</surname><given-names>H.</given-names></name><name><surname>Shao</surname><given-names>N.Y.</given-names></name><name><surname>Mazei-Robison</surname><given-names>M.S.</given-names></name><name><surname>Damez-Werno</surname><given-names>D.</given-names></name><name><surname>Scobie</surname><given-names>K.</given-names></name><name><surname>Bagot</surname><given-names>R.</given-names></name><name><surname>LaBonte</surname><given-names>B.</given-names></name><name><surname>Ribeiro</surname><given-names>E</given-names></name></person-group>, <etal></etal> (<year>2015</year>) 
<article-title>beta-catenin mediates stress resilience through Dicer1/microRNA regulation</article-title>. <source/>Nature, <volume>516</volume>, <fpage>51</fpage>–<lpage>55</lpage>.</mixed-citation>
</ref>
<ref id="ddw131-B57">
<label>57</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gould</surname><given-names>T.D.</given-names></name><name><surname>Chen</surname><given-names>G.</given-names></name><name><surname>Manji</surname><given-names>H.K.</given-names></name></person-group> (<year>2004</year>) 
<article-title>In vivo evidence in the brain for lithium inhibition of glycogen synthase kinase-3</article-title>. <source/>Neuropsychopharmacology, <volume>29</volume>, <fpage>32</fpage>–<lpage>38</lpage>.<pub-id pub-id-type="pmid">12942141</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B58">
<label>58</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Latapy</surname><given-names>C.</given-names></name><name><surname>Rioux</surname><given-names>V.</given-names></name><name><surname>Guitton</surname><given-names>M.J.</given-names></name><name><surname>Beaulieu</surname><given-names>J.M.</given-names></name></person-group> (<year>2012</year>) 
<article-title>Selective deletion of forebrain glycogen synthase kinase 3beta reveals a central role in serotonin-sensitive anxiety and social behaviour</article-title>. <source/>Philos. Trans. R Soc. Lond. B Biol. Sci., <volume>367</volume>, <fpage>2460</fpage>–<lpage>2474</lpage>.<pub-id pub-id-type="pmid">22826345</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B59">
<label>59</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Brien</surname><given-names>W.T.</given-names></name><name><surname>Harper</surname><given-names>A.D.</given-names></name><name><surname>Jove</surname><given-names>F.</given-names></name><name><surname>Woodgett</surname><given-names>J.R.</given-names></name><name><surname>Maretto</surname><given-names>S.</given-names></name><name><surname>Piccolo</surname><given-names>S.</given-names></name><name><surname>Klein</surname><given-names>P.S.</given-names></name></person-group> (<year>2004</year>) 
<article-title>Glycogen synthase kinase-3beta haploinsufficiency mimics the behavioral and molecular effects of lithium</article-title>. <source/>J. Neurosci., <volume>24</volume>, <fpage>6791</fpage>–<lpage>6798</lpage>.<pub-id pub-id-type="pmid">15282284</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B60">
<label>60</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gould</surname><given-names>T.D.</given-names></name><name><surname>Einat</surname><given-names>H.</given-names></name><name><surname>O’Donnell</surname><given-names>K.C.</given-names></name><name><surname>Picchini</surname><given-names>A.M.</given-names></name><name><surname>Schloesser</surname><given-names>R.J.</given-names></name><name><surname>Manji</surname><given-names>H.K.</given-names></name></person-group> (<year>2007</year>) 
<article-title>Beta-catenin overexpression in the mouse brain phenocopies lithium-sensitive behaviors</article-title>. <source/>Neuropsychopharmacology, <volume>32</volume>, <fpage>2173</fpage>–<lpage>2183</lpage>.<pub-id pub-id-type="pmid">17299510</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B61">
<label>61</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beneyto</surname><given-names>M.</given-names></name><name><surname>Lewis</surname><given-names>D.A.</given-names></name></person-group> (<year>2011</year>) 
<article-title>Insights into the neurodevelopmental origin of schizophrenia from postmortem studies of prefrontal cortical circuitry</article-title>. <source/>Int. J. Dev. Neurosci., <volume>29</volume>, <fpage>295</fpage>–<lpage>304</lpage>.<pub-id pub-id-type="pmid">20797429</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B62">
<label>62</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez-Burgos</surname><given-names>G.</given-names></name><name><surname>Cho</surname><given-names>R.Y.</given-names></name><name><surname>Lewis</surname><given-names>D.A.</given-names></name></person-group> (<year>2015</year>) 
<article-title>Alterations in cortical network oscillations and parvalbumin neurons in schizophrenia</article-title>. <source/>Biol. Psychiatry, <volume>77</volume>, <fpage>1031</fpage>–<lpage>1040</lpage>.<pub-id pub-id-type="pmid">25863358</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B63">
<label>63</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yasuda</surname><given-names>Y.</given-names></name><name><surname>Hashimoto</surname><given-names>R.</given-names></name><name><surname>Ohi</surname><given-names>K.</given-names></name><name><surname>Yamamori</surname><given-names>H.</given-names></name><name><surname>Fujimoto</surname><given-names>M.</given-names></name><name><surname>Umeda-Yano</surname><given-names>S.</given-names></name><name><surname>Fujino</surname><given-names>H.</given-names></name><name><surname>Takeda</surname><given-names>M.</given-names></name></person-group> (<year>2014</year>) 
<article-title>Cognitive inflexibility in Japanese adolescents and adults with autism spectrum disorders</article-title>. <source/>World J. Psychiatry, <volume>4</volume>, <fpage>42</fpage>–<lpage>48</lpage>.<pub-id pub-id-type="pmid">25019056</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B64">
<label>64</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Granader</surname><given-names>Y.</given-names></name><name><surname>Wallace</surname><given-names>G.L.</given-names></name><name><surname>Hardy</surname><given-names>K.K.</given-names></name><name><surname>Yerys</surname><given-names>B.E.</given-names></name><name><surname>Lawson</surname><given-names>R.A.</given-names></name><name><surname>Rosenthal</surname><given-names>M.</given-names></name><name><surname>Wills</surname><given-names>M.C.</given-names></name><name><surname>Dixon</surname><given-names>E.</given-names></name><name><surname>Pandey</surname><given-names>J.</given-names></name><name><surname>Penna</surname><given-names>R</given-names></name></person-group>
<etal></etal> (<year>2014</year>) 
<article-title>Characterizing the factor structure of parent reported executive function in autism spectrum disorders: the impact of cognitive inflexibility</article-title>. <source/>J. Autism Dev. Disord., <volume>44</volume>, <fpage>3056</fpage>–<lpage>3062</lpage>.<pub-id pub-id-type="pmid">24972681</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B65">
<label>65</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehninger</surname><given-names>D.</given-names></name><name><surname>Han</surname><given-names>S.</given-names></name><name><surname>Shilyansky</surname><given-names>C.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Kwiatkowski</surname><given-names>D.J.</given-names></name><name><surname>Ramesh</surname><given-names>V.</given-names></name><name><surname>Silva</surname><given-names>A.J.</given-names></name></person-group> (<year>2008</year>) 
<article-title>Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis</article-title>. <source/>Nat. Med., <volume>14</volume>, <fpage>843.</fpage><pub-id pub-id-type="pmid">18568033</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B66">
<label>66</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joseph</surname><given-names>R.M.</given-names></name><name><surname>Keehn</surname><given-names>B.</given-names></name><name><surname>Connolly</surname><given-names>C.</given-names></name><name><surname>Wolfe</surname><given-names>J.M.</given-names></name><name><surname>Horowitz</surname><given-names>T.S.</given-names></name></person-group> (<year>2009</year>) 
<article-title>Why is visual search superior in autism spectrum disorder?</article-title>
<source/>Dev. Sci., <volume>12</volume>, <fpage>1083</fpage>–<lpage>1096</lpage>.<pub-id pub-id-type="pmid">19840062</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B67">
<label>67</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caron</surname><given-names>M.J.</given-names></name><name><surname>Mottron</surname><given-names>L.</given-names></name><name><surname>Rainville</surname><given-names>C.</given-names></name><name><surname>Chouinard</surname><given-names>S.</given-names></name></person-group> (<year>2004</year>) 
<article-title>Do high functioning persons with autism present superior spatial abilities?</article-title>
<source/>Neuropsychologia, <volume>42</volume>, <fpage>467</fpage>–<lpage>481</lpage>.<pub-id pub-id-type="pmid">14728920</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B68">
<label>68</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paina</surname><given-names>S.</given-names></name><name><surname>Garzotto</surname><given-names>D.</given-names></name><name><surname>DeMarchis</surname><given-names>S.</given-names></name><name><surname>Marino</surname><given-names>M.</given-names></name><name><surname>Moiana</surname><given-names>A.</given-names></name><name><surname>Conti</surname><given-names>L.</given-names></name><name><surname>Cattaneo</surname><given-names>E.</given-names></name><name><surname>Perera</surname><given-names>M.</given-names></name><name><surname>Corte</surname><given-names>G.</given-names></name><name><surname>Calautti</surname><given-names>E</given-names></name></person-group>, <etal></etal> (<year>2011</year>) 
<article-title>Wnt5a is a transcriptional target of Dlx homeogenes and promotes differentiation of interneuron progenitors in vitro and in vivo</article-title>. <source/>J. Neurosci., <volume>31</volume>, <fpage>2675</fpage>–<lpage>2687</lpage>.<pub-id pub-id-type="pmid">21325536</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B69">
<label>69</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Lecea</surname><given-names>L.</given-names></name><name><surname>del Rio</surname><given-names>J.A.</given-names></name><name><surname>Soriano</surname><given-names>E.</given-names></name></person-group> (<year>1995</year>) 
<article-title>Developmental expression of parvalbumin mRNA in the cerebral cortex and hippocampus of the rat</article-title>. <source/>Brain Res. Mol. Brain Res., <volume>32</volume>, <fpage>1</fpage>–<lpage>13</lpage>.<pub-id pub-id-type="pmid">7494447</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B70">
<label>70</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tai</surname><given-names>C.Y.</given-names></name><name><surname>Mysore</surname><given-names>S.P.</given-names></name><name><surname>Chiu</surname><given-names>C.</given-names></name><name><surname>Schuman</surname><given-names>E.M.</given-names></name></person-group> (<year>2007</year>) 
<article-title>Activity-regulated N-cadherin endocytosis</article-title>. <source/>Neuron, <volume>54</volume>, <fpage>771</fpage>–<lpage>785</lpage>.<pub-id pub-id-type="pmid">17553425</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B71">
<label>71</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rademakers</surname><given-names>R.</given-names></name><name><surname>Sleegers</surname><given-names>K.</given-names></name><name><surname>Theuns</surname><given-names>J.</given-names></name><name><surname>Van den Broeck</surname><given-names>M.</given-names></name><name><surname>Bel Kacem</surname><given-names>S.</given-names></name><name><surname>Nilsson</surname><given-names>L.G.</given-names></name><name><surname>Adolfsson</surname><given-names>R.</given-names></name><name><surname>van Duijn</surname><given-names>C.M.</given-names></name><name><surname>Van Broeckhoven</surname><given-names>C.</given-names></name><name><surname>Cruts</surname><given-names>M.</given-names></name></person-group> (<year>2005</year>) 
<article-title>Association of cyclin-dependent kinase 5 and neuronal activators p35 and p39 complex in early-onset Alzheimer’s disease</article-title>. <source/>Neurobiol. Aging, <volume>26</volume>, <fpage>1145</fpage>–<lpage>1151</lpage>.<pub-id pub-id-type="pmid">15917097</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B72">
<label>72</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terzian</surname><given-names>A.L.</given-names></name><name><surname>Drago</surname><given-names>F.</given-names></name><name><surname>Wotjak</surname><given-names>C.T.</given-names></name><name><surname>Micale</surname><given-names>V.</given-names></name></person-group> (<year>2011</year>) 
<article-title>The dopamine and cannabinoid interaction in the modulation of emotions and cognition: assessing the role of cannabinoid CB1 receptor in neurons expressing dopamine D1 receptors</article-title>. <source/>Front. Behav. Neurosci., <volume>5</volume>, <fpage>49.</fpage><pub-id pub-id-type="pmid">21887137</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B73">
<label>73</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vorhees</surname><given-names>C.V.</given-names></name><name><surname>Williams</surname><given-names>M.T.</given-names></name></person-group> (<year>2006</year>) 
<article-title>Morris water maze: procedures for assessing spatial and related forms of learning and memory</article-title>. <source/>Nat. Protoc., <volume>1</volume>, <fpage>848</fpage>–<lpage>858</lpage>.<pub-id pub-id-type="pmid">17406317</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B74">
<label>74</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalueff</surname><given-names>A.V.</given-names></name><name><surname>Aldridge</surname><given-names>J.W.</given-names></name><name><surname>LaPorte</surname><given-names>J.L.</given-names></name><name><surname>Murphy</surname><given-names>D.L.</given-names></name><name><surname>Tuohimaa</surname><given-names>P.</given-names></name></person-group> (<year>2007</year>) 
<article-title>Analyzing grooming microstructure in neurobehavioral experiments</article-title>. <source/>Nat. Protoc., <volume>2</volume>, <fpage>2538</fpage>–<lpage>2544</lpage>.<pub-id pub-id-type="pmid">17947996</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B75">
<label>75</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deacon</surname><given-names>R.M.</given-names></name></person-group> (<year>2006</year>) 
<article-title>Digging and marble burying in mice: simple methods for in vivo identification of biological impacts</article-title>. <source/>Nat. Protoc., <volume>1</volume>, <fpage>122</fpage>–<lpage>124</lpage>.<pub-id pub-id-type="pmid">17406223</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B76">
<label>76</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berrocoso</surname><given-names>E.</given-names></name><name><surname>Ikeda</surname><given-names>K.</given-names></name><name><surname>Sora</surname><given-names>I.</given-names></name><name><surname>Uhl</surname><given-names>G.R.</given-names></name><name><surname>Sanchez-Blazquez</surname><given-names>P.</given-names></name><name><surname>Mico</surname><given-names>J.A.</given-names></name></person-group> (<year>2013</year>) 
<article-title>Active behaviours produced by antidepressants and opioids in the mouse tail suspension test</article-title>. <source/>Int. J. Neuropsychopharmacol., <volume>16</volume>, <fpage>151</fpage>–<lpage>162</lpage>.<pub-id pub-id-type="pmid">22217458</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B77">
<label>77</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shiotsuki</surname><given-names>H.</given-names></name><name><surname>Yoshimi</surname><given-names>K.</given-names></name><name><surname>Shimo</surname><given-names>Y.</given-names></name><name><surname>Funayama</surname><given-names>M.</given-names></name><name><surname>Takamatsu</surname><given-names>Y.</given-names></name><name><surname>Ikeda</surname><given-names>K.</given-names></name><name><surname>Takahashi</surname><given-names>R.</given-names></name><name><surname>Kitazawa</surname><given-names>S.</given-names></name><name><surname>Hattori</surname><given-names>N.</given-names></name></person-group> (<year>2010</year>) 
<article-title>A rotarod test for evaluation of motor skill learning</article-title>. <source/>J. Neurosci. Methods, <volume>189</volume>, <fpage>180</fpage>–<lpage>185</lpage>.<pub-id pub-id-type="pmid">20359499</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B78">
<label>78</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deacon</surname><given-names>R.M.</given-names></name></person-group> (<year>2006</year>) 
<article-title>Assessing nest building in mice</article-title>. <source/>Nat. Protoc., <volume>1</volume>, <fpage>1117</fpage>–<lpage>1119</lpage>.<pub-id pub-id-type="pmid">17406392</pub-id></mixed-citation>
</ref>
<ref id="ddw131-B79">
<label>79</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pollak</surname><given-names>D.D.</given-names></name><name><surname>Monje</surname><given-names>F.J.</given-names></name><name><surname>Lubec</surname><given-names>G.</given-names></name></person-group> (<year>2010</year>) 
<article-title>The learned safety paradigm as a mouse model for neuropsychiatric research</article-title>. <source/>Nat. Protoc., <volume>5</volume>, <fpage>954</fpage>–<lpage>962</lpage>.<pub-id pub-id-type="pmid">20431541</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>